{
  "schema_version": "0.1.0",
  "case_id": "HR-ML038",
  "record_classification": {
    "synthetic": true,
    "banner": "SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD",
    "real_historical_name": true,
    "public_release_status": "draft"
  },
  "identity": {
    "person_id": "ML038",
    "display_name": "Babe Didrikson Zaharias",
    "aliases": [
      "Mildred Ella Didrikson",
      "Mildred Didrikson Zaharias",
      "Babe Didrikson",
      "Babe Zaharias"
    ],
    "name_parts": {
      "given": [
        "Mildred",
        "Ella"
      ],
      "family": "Didrikson Zaharias",
      "family_first": false
    },
    "sex": "female",
    "era": "Mid-Late 20th Century",
    "nationality": "American",
    "historical_dates": {
      "birth": {
        "preferred": {
          "iso": "1911-06-26",
          "display": "June 26, 1911",
          "precision": "day",
          "calendar": "gregorian"
        },
        "alternatives": [
          {
            "date": {
              "iso": "1911",
              "display": "1911",
              "precision": "year",
              "calendar": "gregorian"
            },
            "source_ids": [
              "SRC-0007"
            ],
            "resolution_status": "preferred",
            "note": "Roster year agrees with the Handbook of Texas and the National Women's History Museum."
          },
          {
            "date": {
              "iso": "1914",
              "display": "1914",
              "precision": "year",
              "calendar": "gregorian"
            },
            "source_ids": [
              "SRC-0004"
            ],
            "resolution_status": "conflicting",
            "note": "The year she wrote on her 1932 Olympic application; her baptismal certificate and gravestone support 1911."
          }
        ]
      },
      "death": {
        "preferred": {
          "iso": "1956-09-27",
          "display": "September 27, 1956",
          "precision": "day",
          "calendar": "gregorian"
        },
        "alternatives": [
          {
            "date": {
              "iso": "1956",
              "display": "1956",
              "precision": "year",
              "calendar": "gregorian"
            },
            "source_ids": [
              "SRC-0007"
            ],
            "resolution_status": "preferred",
            "note": "Roster year agrees with the Handbook of Texas."
          },
          {
            "date": {
              "iso": "1956-09-26",
              "display": "September 26, 1956",
              "precision": "day",
              "calendar": "gregorian"
            },
            "source_ids": [
              "SRC-0003"
            ],
            "resolution_status": "conflicting",
            "note": "Women in World History gives September 26; the Handbook of Texas, the foundation and the New York Times report give September 27."
          }
        ]
      }
    },
    "synthetic_identity": {
      "mrn": "HR-ML038-SYN",
      "ssn": "000-38-4471",
      "date_of_birth": "1984-06-26",
      "name_policy": "real_historical_name",
      "fictional_facility": "St. Posthumous Health Center",
      "fictional_primary_clinician": "Rosalind Vasquez-Thornbury, MD",
      "fictional_consultant": {
        "name": "Jun-Ho Albright-Nakamura, MD",
        "specialty": "Medical Oncology (gastrointestinal)"
      }
    }
  },
  "historical_timeline": [
    {
      "event_id": "EVT-0001",
      "date": {
        "iso": "1911-06-26",
        "display": "June 26, 1911",
        "precision": "day",
        "calendar": "gregorian"
      },
      "summary": "Born in Port Arthur, Texas; the family moves to Beaumont in 1915.",
      "claim_ids": [
        "CLM-0001",
        "CLM-0002"
      ]
    },
    {
      "event_id": "EVT-0002",
      "date": {
        "iso": "1932",
        "display": "1932",
        "precision": "year",
        "calendar": "gregorian"
      },
      "summary": "Wins two gold medals and a silver medal in track and field at the Los Angeles Olympic Games.",
      "claim_ids": [
        "CLM-0003"
      ]
    },
    {
      "event_id": "EVT-0003",
      "date": {
        "iso": "1938-12-23",
        "display": "December 23, 1938",
        "precision": "day",
        "calendar": "gregorian"
      },
      "summary": "Marries George Zaharias.",
      "claim_ids": [
        "CLM-0004"
      ]
    },
    {
      "event_id": "EVT-0004",
      "date": {
        "iso": "1950",
        "display": "1950",
        "precision": "year",
        "calendar": "gregorian"
      },
      "summary": "Voted Associated Press Woman Athlete of the Half-Century, a year after co-founding the LPGA; about this time she buys the Tampa Golf and Country Club and lives there.",
      "claim_ids": [
        "CLM-0005"
      ]
    },
    {
      "event_id": "EVT-0005",
      "date": {
        "iso": "1952",
        "display": "End of 1952",
        "precision": "year",
        "calendar": "gregorian"
      },
      "summary": "Extremely fatigued by the end of the golf season.",
      "claim_ids": [
        "CLM-0006"
      ]
    },
    {
      "event_id": "EVT-0006",
      "date": {
        "iso": "1953-04-17",
        "display": "April 17, 1953",
        "precision": "day",
        "calendar": "gregorian"
      },
      "summary": "Diagnosed with cancer in April 1953; operation including a colostomy in Beaumont.",
      "claim_ids": [
        "CLM-0007",
        "CLM-0008"
      ]
    },
    {
      "event_id": "EVT-0007",
      "date": {
        "iso": "1954-07",
        "display": "July 1954",
        "precision": "month",
        "calendar": "gregorian"
      },
      "summary": "Wins the U.S. Women's Open by twelve strokes, 14 months after the operation.",
      "claim_ids": [
        "CLM-0009"
      ]
    },
    {
      "event_id": "EVT-0008",
      "date": {
        "iso": "1955",
        "display": "1955",
        "precision": "year",
        "calendar": "gregorian"
      },
      "summary": "The cancer returns; she re-enters John Sealy Hospital in Galveston in June and sets up a cancer fund with her husband in September.",
      "claim_ids": [
        "CLM-0010",
        "CLM-0011"
      ]
    },
    {
      "event_id": "EVT-0009",
      "date": {
        "iso": "1956-09-27",
        "display": "September 27, 1956",
        "precision": "day",
        "calendar": "gregorian"
      },
      "summary": "Dies of cancer at John Sealy Hospital in Galveston at 45.",
      "claim_ids": [
        "CLM-0012"
      ]
    }
  ],
  "claims": [
    {
      "claim_id": "CLM-0001",
      "statement": "Mildred Ella Didrikson was born in Port Arthur, Texas, on June 26, 1911, the sixth of seven children of the Norwegian immigrants Ole Nickolene and Hannah Marie (Olson) Didriksen; she later changed the spelling of her surname. In 1915 the family moved to Beaumont, Texas.",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "source_links": [
        {
          "source_id": "SRC-0001",
          "relationship": "supports",
          "locator": "born on June 26, 1911, in Port Arthur, Texas, the sixth of seven children of Norwegian immigrants Ole Nickolene and Hannah Marie (Olson) Didriksen; changed the spelling of her surname; in 1915 the family moved to Beaumont"
        },
        {
          "source_id": "SRC-0002",
          "relationship": "supports",
          "locator": "Born on June 26, 1911 in Port Arthur, Texas, she was the sixth of seven children"
        },
        {
          "source_id": "SRC-0007",
          "relationship": "context",
          "locator": "roster birth date"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    },
    {
      "claim_id": "CLM-0002",
      "statement": "Her birth year is given variously: she wrote 1914 on her application for the 1932 Olympics, and some sources, including a historical marker at her grave, give 1913, 1914 or 1915; her gravestone and baptismal certificate support 1911.",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "clinical_interpretation": "Explains why her age is given differently, including in her obituaries; 1911 is used.",
      "source_links": [
        {
          "source_id": "SRC-0004",
          "relationship": "supports",
          "locator": "on her application for the 1932 Olympics, she wrote that she was born in 1914; her gravestone and her baptismal certificate corroborate the earlier 1911 date"
        },
        {
          "source_id": "SRC-0003",
          "relationship": "supports",
          "locator": "some sources, including the Texas State Historical Marker at her gravesite, state 1913; others 1914 or 1915, but 1911 is documented"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    },
    {
      "claim_id": "CLM-0003",
      "statement": "At the 1932 Olympic Games in Los Angeles she won gold medals in the javelin and the 80-meter hurdles and a silver medal in the high jump, where her head-first technique was ruled a foul.",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "clinical_interpretation": "Anchors the modern social history: an elite athlete all her adult life.",
      "source_links": [
        {
          "source_id": "SRC-0001",
          "relationship": "supports",
          "locator": "won gold medals for the javelin and hurdles; silver in the high jump because she went over the bar head first, a foul at that time"
        },
        {
          "source_id": "SRC-0002",
          "relationship": "supports",
          "locator": "gold medal for the javelin throw; 11.7 seconds in the 80-meter hurdle; silver medal in the high jump"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    },
    {
      "claim_id": "CLM-0004",
      "statement": "She met the professional wrestler George Zaharias at the 1938 Los Angeles Open, and they married on December 23, 1938; he became her manager.",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "clinical_interpretation": "History only; her husband is given no role in the modern episode.",
      "source_links": [
        {
          "source_id": "SRC-0001",
          "relationship": "supports",
          "locator": "met at the 1938 Los Angeles Open; married on December 23, 1938"
        },
        {
          "source_id": "SRC-0002",
          "relationship": "supports",
          "locator": "a wrestler and part-time actor from Colorado; they married in December 1938, and Zaharias became his wife's manager"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    },
    {
      "claim_id": "CLM-0005",
      "statement": "She took up golf in 1933, won 17 amateur tournaments in a row between 1943 and 1947, co-founded the Ladies Professional Golf Association in 1949, and was voted the Associated Press Woman Athlete of the Half-Century in 1950. About 1950 she and her husband bought the Tampa Golf and Country Club in Florida and moved into its converted clubhouse.",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "clinical_interpretation": "Anchors the modern social history: a professional golfer who lives at the golf club she owns in Tampa.",
      "source_links": [
        {
          "source_id": "SRC-0002",
          "relationship": "supports",
          "locator": "took up golf in 1933; between 1943 and 1947 she won 17 amateur tournaments in a row; co-found the LPGA in 1949; in 1950 the Associated Press voted Babe Didrikson Woman Athlete of the Half-Century"
        },
        {
          "source_id": "SRC-0004",
          "relationship": "supports",
          "locator": "bought the Tampa Golf and Country Club and moved into the large converted clubhouse there"
        },
        {
          "source_id": "SRC-0005",
          "relationship": "supports",
          "locator": "They lived in Denver and Tampa"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    },
    {
      "claim_id": "CLM-0006",
      "statement": "By the end of the 1952 golf season she was feeling extremely fatigued.",
      "evidence_grade": "D",
      "certainty": "probable",
      "clinical_interpretation": "The anchor for the modern presenting problem (fatigue, rectal bleeding and a change in bowel habit). One source only; no other symptom before the diagnosis was found in the sources read.",
      "source_links": [
        {
          "source_id": "SRC-0004",
          "relationship": "supports",
          "locator": "Zaharias was feeling extremely fatigued by the end of the 1952 season"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    },
    {
      "claim_id": "CLM-0007",
      "statement": "She was diagnosed with cancer in April 1953 and had an operation that included a colostomy on April 17, 1953, in Beaumont, Texas. She missed the 1953 U.S. Women's Open while she recovered.",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "clinical_interpretation": "The documented diagnosis and operation to which the modern diagnosis is linked. The colostomy was permanent; the modern episode avoids one.",
      "source_links": [
        {
          "source_id": "SRC-0001",
          "relationship": "supports",
          "locator": "In April 1953 Didrikson underwent a colostomy to remove cancerous tissue"
        },
        {
          "source_id": "SRC-0005",
          "relationship": "supports",
          "locator": "diagnosed with colon cancer in 1953 and had surgery involving a colostomy on April 17, 1953, in Beaumont"
        },
        {
          "source_id": "SRC-0004",
          "relationship": "supports",
          "locator": "In April of 1953 she was diagnosed with colon cancer"
        },
        {
          "source_id": "SRC-0002",
          "relationship": "supports",
          "locator": "In 1953 Didrikson was diagnosed with cancer and underwent surgery including a colostomy"
        },
        {
          "source_id": "SRC-0006",
          "relationship": "supports",
          "locator": "missed the event in 1953 while recovering from surgery for colon cancer"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    },
    {
      "claim_id": "CLM-0008",
      "statement": "The sources read call her cancer colon cancer and do not name the operation or give any pathology. That it was a low rectal cancer removed by abdominoperineal resection is a retrospective reading of the permanent colostomy, which was then the usual result of that operation; some popular accounts call it rectal cancer.",
      "evidence_grade": "R",
      "certainty": "possible",
      "clinical_interpretation": "Retrospective. The modern episode uses a low rectal adenocarcinoma, which fits a permanent colostomy in 1953; this is a teaching choice, not a resolution of the historical question.",
      "source_links": [
        {
          "source_id": "SRC-0005",
          "relationship": "context",
          "locator": "diagnosed with colon cancer; surgery involving a colostomy"
        },
        {
          "source_id": "SRC-0003",
          "relationship": "context",
          "locator": "battled colon cancer"
        },
        {
          "source_id": "SRC-0006",
          "relationship": "context",
          "locator": "won while wearing a colostomy bag (1954 Open article)"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    },
    {
      "claim_id": "CLM-0009",
      "statement": "She was back in tournament competition 14 weeks after the operation, received the Ben Hogan Comeback Player of the Year award for 1954, and in 1954 won five tournaments, including the U.S. Women's Open, played on July 1 to 3 at Salem Country Club in Peabody, Massachusetts, which she won by twelve strokes.",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "clinical_interpretation": "Documented return to elite sport after the operation; the modern plan is built around her golf.",
      "source_links": [
        {
          "source_id": "SRC-0003",
          "relationship": "supports",
          "locator": "staging a dramatic athletic comeback a mere 14 weeks after her surgery; Ben Hogan Comeback Player of the Year Award (1954)"
        },
        {
          "source_id": "SRC-0001",
          "relationship": "supports",
          "locator": "In 1954 she won five tournaments, including the United States Women's Open"
        },
        {
          "source_id": "SRC-0006",
          "relationship": "supports",
          "locator": "held July 1-3 at Salem Country Club in Peabody, Massachusetts; won her third U.S. Women's Open, twelve strokes ahead of runner-up Betty Hicks"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    },
    {
      "claim_id": "CLM-0010",
      "statement": "The cancer returned in 1955: back surgery that year found cancer near her sacrum, and in June 1955 she re-entered John Sealy Hospital at the University of Texas Medical Branch in Galveston, where treatment could not contain its spread.",
      "evidence_grade": "D",
      "certainty": "probable",
      "clinical_interpretation": "Documented recurrence after the episode; history only.",
      "source_links": [
        {
          "source_id": "SRC-0001",
          "relationship": "supports",
          "locator": "In June 1955 she was forced to reenter John Sealy Hospital at UTMB; medical treatment was unable to contain the spreading cancer"
        },
        {
          "source_id": "SRC-0006",
          "relationship": "supports",
          "locator": "back surgery, which discovered that cancer had recurred near her sacrum"
        },
        {
          "source_id": "SRC-0005",
          "relationship": "supports",
          "locator": "In 1955, had back surgery and by 1956, the cancer has spread"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    },
    {
      "claim_id": "CLM-0011",
      "statement": "She was one of the first public figures to speak openly about her cancer, and raised money and awareness for cancer education and research; in September 1955 she and her husband set up the Babe Didrikson Zaharias Fund, which financed a tumor clinic at the University of Texas Medical Branch. The American Cancer Society gave her a certificate of appreciation.",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "clinical_interpretation": "Her documented openness about cancer anchors the modern plan's attention to screening of relatives and public education.",
      "source_links": [
        {
          "source_id": "SRC-0005",
          "relationship": "supports",
          "locator": "one of the first public figures to openly discuss her cancer in an attempt to spread awareness about the disease"
        },
        {
          "source_id": "SRC-0003",
          "relationship": "supports",
          "locator": "devoted herself to fund and consciousness raising for the disease; American Cancer Society Certificate of Appreciation"
        },
        {
          "source_id": "SRC-0001",
          "relationship": "supports",
          "locator": "In September 1955 established the Babe Didrikson Zaharias Fund, which financed a tumor clinic at UTMB"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    },
    {
      "claim_id": "CLM-0012",
      "statement": "She died of cancer at John Sealy Hospital in Galveston, Texas, on September 27, 1956, at 45, and was buried in Beaumont. One reference work gives September 26, and the contemporary New York Times report gave her age as 42.",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "clinical_interpretation": "The documented death from cancer, to which the synthetic diagnosis is linked. History only, stated without detail.",
      "source_links": [
        {
          "source_id": "SRC-0001",
          "relationship": "supports",
          "locator": "died at John Sealy Hospital on September 27, 1956, at the age of forty-five; buried in Beaumont"
        },
        {
          "source_id": "SRC-0005",
          "relationship": "supports",
          "locator": "age 45, died at John Sealy Hospital in Galveston, Texas from colon cancer, September 27, 1956"
        },
        {
          "source_id": "SRC-0003",
          "relationship": "supports",
          "locator": "succumbed to cancer at John Sealy Hospital in Galveston, Texas, on September 26, 1956"
        },
        {
          "source_id": "SRC-0004",
          "relationship": "supports",
          "locator": "the 1956 New York Times obituary, dated September 28, gives her age as 42"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    }
  ],
  "sources": [
    {
      "source_id": "SRC-0001",
      "title": "Cayleff SE. Zaharias, Mildred Ella Didrikson [Babe] (Handbook of Texas Online)",
      "publisher": "Texas State Historical Association",
      "url": "https://www.tshaonline.org/handbook/entries/zaharias-mildred-ella-didrikson-babe",
      "source_type": "other",
      "published": "2022-05-11",
      "accessed": "2026-11-05",
      "rights_note": "State historical reference entry by her biographer; facts and short quotations used with citation."
    },
    {
      "source_id": "SRC-0002",
      "title": "Michals D, ed. Mildred \"Babe\" Didrikson Zaharias",
      "publisher": "National Women's History Museum",
      "url": "https://www.womenshistory.org/education-resources/biographies/mildred-zaharias",
      "source_type": "other",
      "published": "2015",
      "accessed": "2026-11-05",
      "rights_note": "Museum biography; facts and short quotations used with citation."
    },
    {
      "source_id": "SRC-0003",
      "title": "Zaharias, Babe Didrikson (1911-1956) (Women in World History: A Biographical Encyclopedia)",
      "publisher": "Encyclopedia.com (Gale)",
      "url": "https://www.encyclopedia.com/women/encyclopedias-almanacs-transcripts-and-maps/zaharias-babe-didrikson-1911-1956",
      "source_type": "other",
      "accessed": "2026-11-05",
      "rights_note": "Reference encyclopedia entry; facts and short quotations used with citation; it gives the death date as September 26."
    },
    {
      "source_id": "SRC-0004",
      "title": "Winters K. Zaharias, Babe Didrikson (Notable Sports Figures)",
      "publisher": "Encyclopedia.com (Gale)",
      "url": "https://www.encyclopedia.com/people/sports-and-games/sports-biographies/babe-didrikson-zaharias",
      "source_type": "other",
      "accessed": "2026-11-05",
      "rights_note": "Reference encyclopedia entry; used for the fatigue at the end of 1952, the April 1953 diagnosis, the Tampa club, the birth-year evidence and its quotation of the New York Times obituary; it contains errors about the 1954 Open and is not used for that."
    },
    {
      "source_id": "SRC-0005",
      "title": "The Life and Achievements of Babe Didrikson Zaharias",
      "publisher": "Babe Didrikson Zaharias Foundation",
      "url": "https://bdzfoundation.com/about-babe-didrikson-zaharias/",
      "source_type": "other",
      "accessed": "2026-11-05",
      "rights_note": "Foundation biography; used for the date and place of the operation, her openness about cancer, and her death."
    },
    {
      "source_id": "SRC-0006",
      "title": "1954 U.S. Women's Open; 1953 U.S. Women's Open",
      "publisher": "Wikipedia",
      "url": "https://en.wikipedia.org/wiki/1954_U.S._Women%27s_Open",
      "source_type": "other",
      "accessed": "2026-11-05",
      "rights_note": "Tertiary source citing contemporary wire reports; used for the dates, venue and margin of the 1954 championship, her absence in 1953 (https://en.wikipedia.org/wiki/1953_U.S._Women%27s_Open), the recurrence near the sacrum, and as a pointer to its sources."
    },
    {
      "source_id": "SRC-0007",
      "title": "HISTMED Master Roster v3",
      "publisher": "The Human Record project",
      "url": "https://humanrecord.example.org/internal/HISTMED_Master_Roster_v3.xlsx",
      "source_type": "other",
      "published": "2026-11-05",
      "accessed": "2026-11-05",
      "rights_note": "Internal source locator; inherited claims remain provisional until corroborated."
    }
  ],
  "synthetic_episode": {
    "calendar_frame": "modern_shifted",
    "index_date": "2026-03-16",
    "index_age": 41,
    "date_shift_policy": "HR-DATE-SHIFT-1",
    "teaching_objective": "Recognize early-onset rectal cancer in a fit woman of 41, below the screening age, whose rectal bleeding and change in bowel habit could be put down to hemorrhoids, and care for it on the NCCN rectal cancer guideline and the ASCO guidance on locally advanced rectal cancer: a digital rectal examination and prompt colonoscopy with biopsy; mismatch repair testing of every colorectal cancer; germline genetic testing because she is under 50; staging by pelvic MRI and CT, with CEA; a multidisciplinary tumor board; and, because the tumor is mismatch repair deficient, PD-1 blockade with dostarlimab and a watch-and-wait strategy after a clinical complete response, sparing her the abdominoperineal resection and permanent colostomy that a tumor this low would otherwise need. The episode also covers immune-related adverse events (hypothyroidism), iron deficiency anemia, sexual health and body image, return to elite sport, screening of first-degree relatives, the USPSTF screening age of 45, and survivorship care, set against her documented operation with a permanent colostomy in 1953 and her return to win a national championship afterwards.",
    "visit_schedule": [
      {
        "encounter_id": "ENC-001",
        "date": "2026-03-16",
        "purpose": "Three months of rectal bleeding, narrower stools and urgency, with tiredness, in a professional golfer of 41: examination, blood tests, and colonoscopy this week"
      },
      {
        "encounter_id": "ENC-002",
        "date": "2026-03-30",
        "purpose": "Diagnosis of mismatch repair-deficient low rectal cancer: staging, tumor board plan, medical oncology and colorectal surgery consultation, genetic counseling, and the start of PD-1 blockade"
      },
      {
        "encounter_id": "ENC-003",
        "date": "2026-04-27",
        "purpose": "Day 1 of cycle 2 of dostarlimab: early response, immune-related adverse event checks, germline and tumor genetic results, iron and anemia, and golf"
      },
      {
        "encounter_id": "ENC-006",
        "date": "2026-06-01",
        "purpose": "Same-day sick visit for cough and sore throat during immunotherapy"
      },
      {
        "encounter_id": "ENC-004",
        "date": "2026-06-29",
        "purpose": "Restaging after four doses: pelvic MRI and endoscopy, immune-related hypothyroidism, and the decision to continue PD-1 blockade"
      },
      {
        "encounter_id": "ENC-007",
        "date": "2026-08-10",
        "purpose": "Periodic adult preventive visit during immunotherapy"
      },
      {
        "encounter_id": "ENC-005",
        "date": "2026-10-05",
        "purpose": "After nine doses: final restaging, clinical complete response, and the watch-and-wait surveillance plan"
      }
    ]
  },
  "clinical": {
    "problems": [
      {
        "id": "PRB-001",
        "display": "Bright red blood with bowel movements for about three months, with narrower stools, urgency, a feeling of incomplete emptying, and a firm, ulcerated mass felt on the back wall of the lower rectum at about 5 cm from the anal verge: a rectal cancer must be confirmed or excluded. Colonoscopy with biopsy booked this week",
        "status": "draft",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/icd-10-cm",
            "code": "K62.5",
            "display": "Hemorrhage of anus and rectum",
            "version": "FY2026",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0006"
          ],
          "synthetic_reason": "Synthetic presenting problem anchored to the documented fatigue before her cancer diagnosis. Superseded by the diagnosis at the second visit.",
          "author": "The Human Record generator",
          "created": "2026-11-05T10:00:00-05:00"
        },
        "clinical_status": "resolved",
        "verification_status": "confirmed",
        "problem_placement": "active",
        "abatement_date": "2026-03-30"
      },
      {
        "id": "PRB-002",
        "display": "Iron deficiency anemia from chronic rectal blood loss: hemoglobin 11.0 g/dL, MCV 77 fL, ferritin 9 ng/mL, with tiredness",
        "status": "draft",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/icd-10-cm",
            "code": "D50.0",
            "display": "Iron deficiency anemia secondary to blood loss (chronic)",
            "version": "FY2026",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0006"
          ],
          "synthetic_reason": "Synthetic finding anchored to the documented fatigue at the end of the 1952 season.",
          "author": "The Human Record generator",
          "created": "2026-11-05T10:00:00-05:00"
        },
        "clinical_status": "active",
        "verification_status": "confirmed",
        "problem_placement": "active"
      },
      {
        "id": "PRB-003",
        "display": "Adenocarcinoma of the low rectum, mismatch repair deficient (loss of MSH2 and MSH6; microsatellite instability high), cT3bN1M0 (stage IIIB) on pelvic MRI, lower edge 4 cm from the anal verge and about 1 cm above the anorectal junction, mesorectal fascia clear, no extramural venous invasion; CEA 5.8 ng/mL; synthetic modern detail linked to her documented cancer, whose site the sources do not record exactly",
        "status": "draft",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/icd-10-cm",
            "code": "C20",
            "display": "Malignant neoplasm of rectum",
            "version": "FY2026",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007",
            "CLM-0012",
            "CLM-0008"
          ],
          "synthetic_reason": "Synthetic histology, site, stage, mismatch repair status and course; the sources say she had cancer treated with a colostomy and call it colon cancer (R on the site). See sources.md.",
          "author": "The Human Record generator",
          "created": "2026-11-05T10:00:00-05:00"
        },
        "clinical_status": "active",
        "verification_status": "confirmed",
        "problem_placement": "both_with_link",
        "recorded_date": "2026-03-30"
      },
      {
        "id": "PRB-005",
        "display": "Acute viral upper respiratory infection with cough and sore throat, a week before cycle 4 of dostarlimab; oxygen saturation and chest X-ray normal, so immune-related pneumonitis is unlikely; rapid influenza and COVID-19 tests negative; resolved",
        "status": "draft",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/icd-10-cm",
            "code": "J06.9",
            "display": "Acute upper respiratory infection, unspecified",
            "version": "FY2026",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007",
            "CLM-0012"
          ],
          "synthetic_reason": "Synthetic intercurrent illness; not a historical claim.",
          "author": "The Human Record generator",
          "created": "2026-11-05T10:30:00-05:00"
        },
        "clinical_status": "resolved",
        "verification_status": "confirmed",
        "problem_placement": "active",
        "recorded_date": "2026-06-01",
        "abatement_date": "2026-06-29"
      },
      {
        "id": "PRB-004",
        "display": "Immune-related primary hypothyroidism from dostarlimab, grade 2: tiredness and cold hands, TSH 12.6 mIU/L and free T4 0.6 ng/dL after four doses, following a mild TSH rise four weeks earlier; dostarlimab continued",
        "status": "draft",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/icd-10-cm",
            "code": "E03.2",
            "display": "Hypothyroidism due to medicaments and other exogenous substances",
            "version": "FY2026",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007",
            "CLM-0012"
          ],
          "synthetic_reason": "Synthetic common immune-related adverse event of PD-1 blockade.",
          "author": "The Human Record generator",
          "created": "2026-11-05T11:00:00-05:00"
        },
        "clinical_status": "active",
        "verification_status": "confirmed",
        "problem_placement": "active",
        "recorded_date": "2026-06-29"
      }
    ],
    "medications": [
      {
        "id": "MED-001",
        "display": "Ferrous sulfate 325 mg (65 mg elemental iron) oral tablet, one tablet by mouth every other morning",
        "status": "active",
        "coding": [
          {
            "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
            "code": "310325",
            "display": "ferrous sulfate 325 MG Oral Tablet",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "dose": {
          "value": 1,
          "unit": "1"
        },
        "route": "oral",
        "frequency": {
          "period": 2,
          "period_unit": "d",
          "text": "One tablet every other morning"
        },
        "start_date": "2026-03-30",
        "indication_problem_ids": [
          "PRB-002"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007",
            "CLM-0012"
          ],
          "synthetic_reason": "Synthetic oral iron on alternate days for iron deficiency anemia from rectal blood loss; alternate-day dosing is absorbed as well and better tolerated.",
          "author": "The Human Record generator",
          "created": "2026-11-05T11:00:00-05:00"
        }
      },
      {
        "id": "MED-002",
        "display": "Dostarlimab-gxly 50 mg/mL injection, 500 mg intravenously over 30 minutes every 3 weeks, for nine doses (six months)",
        "status": "completed",
        "coding": [
          {
            "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
            "code": "2539972",
            "display": "10 ML dostarlimab-gxly 50 MG/ML Injection",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "dose": {
          "value": 500,
          "unit": "mg"
        },
        "route": "intravenous",
        "frequency": {
          "period": 21,
          "period_unit": "d",
          "text": "500 mg every 3 weeks for nine doses"
        },
        "start_date": "2026-04-06",
        "end_date": "2026-09-21",
        "indication_problem_ids": [
          "PRB-003"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007",
            "CLM-0012"
          ],
          "synthetic_reason": "Synthetic PD-1 blockade for mismatch repair-deficient locally advanced rectal cancer, as in the dostarlimab trial.",
          "author": "The Human Record generator",
          "created": "2026-11-05T11:00:00-05:00"
        }
      },
      {
        "id": "MED-003",
        "display": "Levothyroxine 75 microgram oral tablet, one tablet by mouth each morning on an empty stomach, four hours apart from iron",
        "status": "active",
        "coding": [
          {
            "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
            "code": "966222",
            "display": "levothyroxine sodium 0.075 MG Oral Tablet",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "dose": {
          "value": 1,
          "unit": "1"
        },
        "route": "oral",
        "frequency": {
          "period": 1,
          "period_unit": "d",
          "text": "One tablet each morning"
        },
        "start_date": "2026-06-29",
        "indication_problem_ids": [
          "PRB-004"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007",
            "CLM-0012"
          ],
          "synthetic_reason": "Synthetic thyroid replacement for immune-related hypothyroidism (about 1.2 micrograms per kg).",
          "author": "The Human Record generator",
          "created": "2026-11-05T11:00:00-05:00"
        }
      }
    ],
    "allergies": [
      {
        "id": "ALG-001",
        "display": "No known allergy",
        "status": "active",
        "assertion": "no_known_allergy",
        "substance": {
          "system": "http://snomed.info/sct",
          "code": "716186003",
          "display": "No known allergy"
        },
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic allergy assertion for EHR completeness; not a historical assertion.",
          "author": "The Human Record generator",
          "created": "2026-11-05T10:00:00-05:00"
        }
      }
    ],
    "observations": [
      {
        "id": "OBS-HGB-V1",
        "display": "Hemoglobin [Mass/volume] in Blood",
        "label": "Hemoglobin",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-03-16",
        "value": 11.0,
        "unit": "g/dL",
        "reference_range": {
          "low": 12.0,
          "high": 15.5
        },
        "interpretation": "L",
        "panel": {
          "code": "58410-2",
          "display": "CBC panel - Blood by Automated count"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "718-7",
            "display": "Hemoglobin [Mass/volume] in Blood",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0006"
          ],
          "synthetic_reason": "Synthetic blood count at presentation: microcytic anemia after months of rectal bleeding. No result from her life is known; synthetic value.",
          "author": "The Human Record generator",
          "created": "2026-11-05T10:00:00-05:00"
        }
      },
      {
        "id": "OBS-MCV-V1",
        "display": "MCV [Entitic mean volume] in Red Blood Cells by Automated count",
        "label": "MCV",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-03-16",
        "value": 77,
        "unit": "fL",
        "reference_range": {
          "low": 80,
          "high": 100
        },
        "interpretation": "L",
        "panel": {
          "code": "58410-2",
          "display": "CBC panel - Blood by Automated count"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "787-2",
            "display": "MCV [Entitic mean volume] in Red Blood Cells by Automated count",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0006"
          ],
          "synthetic_reason": "Synthetic blood count at presentation: microcytic anemia after months of rectal bleeding. No result from her life is known; synthetic value.",
          "author": "The Human Record generator",
          "created": "2026-11-05T10:00:00-05:00"
        }
      },
      {
        "id": "OBS-WBC-V1",
        "display": "Leukocytes [#/volume] in Blood by Automated count",
        "label": "White cell count",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-03-16",
        "value": 6.8,
        "unit": "10*3/uL",
        "reference_range": {
          "low": 4.0,
          "high": 11.0
        },
        "interpretation": "N",
        "panel": {
          "code": "58410-2",
          "display": "CBC panel - Blood by Automated count"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "6690-2",
            "display": "Leukocytes [#/volume] in Blood by Automated count",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0006"
          ],
          "synthetic_reason": "Synthetic blood count at presentation: microcytic anemia after months of rectal bleeding. No result from her life is known; synthetic value.",
          "author": "The Human Record generator",
          "created": "2026-11-05T10:00:00-05:00"
        }
      },
      {
        "id": "OBS-PLT-V1",
        "display": "Platelets [#/volume] in Blood by Automated count",
        "label": "Platelets",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-03-16",
        "value": 412,
        "unit": "10*3/uL",
        "reference_range": {
          "low": 150,
          "high": 400
        },
        "interpretation": "H",
        "panel": {
          "code": "58410-2",
          "display": "CBC panel - Blood by Automated count"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "777-3",
            "display": "Platelets [#/volume] in Blood by Automated count",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0006"
          ],
          "synthetic_reason": "Synthetic blood count at presentation: microcytic anemia after months of rectal bleeding. No result from her life is known; synthetic value.",
          "author": "The Human Record generator",
          "created": "2026-11-05T10:00:00-05:00"
        }
      },
      {
        "id": "OBS-FERR-V1",
        "display": "Ferritin [Mass/volume] in Serum or Plasma",
        "label": "Ferritin",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-03-16",
        "value": 9,
        "unit": "ng/mL",
        "reference_range": {
          "low": 15,
          "high": 150
        },
        "interpretation": "L",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2276-4",
            "display": "Ferritin [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0006"
          ],
          "synthetic_reason": "Synthetic ferritin: iron deficiency from chronic blood loss.",
          "author": "The Human Record generator",
          "created": "2026-11-05T10:00:00-05:00"
        }
      },
      {
        "id": "OBS-NA-V1",
        "display": "Sodium [Moles/volume] in Serum or Plasma",
        "label": "Sodium",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-03-16",
        "value": 139,
        "unit": "mmol/L",
        "reference_range": {
          "low": 135,
          "high": 145
        },
        "interpretation": "N",
        "panel": {
          "code": "24323-8",
          "display": "Comprehensive metabolic 2000 panel - Serum or Plasma"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2951-2",
            "display": "Sodium [Moles/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0006"
          ],
          "synthetic_reason": "Synthetic chemistry at presentation; normal liver tests.",
          "author": "The Human Record generator",
          "created": "2026-11-05T10:00:00-05:00"
        }
      },
      {
        "id": "OBS-K-V1",
        "display": "Potassium [Moles/volume] in Serum or Plasma",
        "label": "Potassium",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-03-16",
        "value": 4.1,
        "unit": "mmol/L",
        "reference_range": {
          "low": 3.5,
          "high": 5.1
        },
        "interpretation": "N",
        "panel": {
          "code": "24323-8",
          "display": "Comprehensive metabolic 2000 panel - Serum or Plasma"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2823-3",
            "display": "Potassium [Moles/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0006"
          ],
          "synthetic_reason": "Synthetic chemistry at presentation; normal liver tests.",
          "author": "The Human Record generator",
          "created": "2026-11-05T10:00:00-05:00"
        }
      },
      {
        "id": "OBS-CR-V1",
        "display": "Creatinine [Mass/volume] in Serum or Plasma",
        "label": "Creatinine",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-03-16",
        "value": 0.78,
        "unit": "mg/dL",
        "reference_range": {
          "low": 0.59,
          "high": 1.04
        },
        "interpretation": "N",
        "panel": {
          "code": "24323-8",
          "display": "Comprehensive metabolic 2000 panel - Serum or Plasma"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2160-0",
            "display": "Creatinine [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0006"
          ],
          "synthetic_reason": "Synthetic chemistry at presentation; normal liver tests.",
          "author": "The Human Record generator",
          "created": "2026-11-05T10:00:00-05:00"
        }
      },
      {
        "id": "OBS-EGFR-V1",
        "display": "Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M",
        "label": "eGFR (CKD-EPI 2021)",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-03-16",
        "value": 98,
        "unit": "mL/min/{1.73_m2}",
        "reference_range": {
          "low": 60
        },
        "interpretation": "N",
        "panel": {
          "code": "24323-8",
          "display": "Comprehensive metabolic 2000 panel - Serum or Plasma"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "98979-8",
            "display": "Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0006"
          ],
          "synthetic_reason": "Synthetic chemistry at presentation; normal liver tests.",
          "author": "The Human Record generator",
          "created": "2026-11-05T10:00:00-05:00"
        }
      },
      {
        "id": "OBS-GLU-V1",
        "display": "Glucose [Mass/volume] in Serum or Plasma",
        "label": "Glucose",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-03-16",
        "value": 88,
        "unit": "mg/dL",
        "reference_range": {
          "low": 70,
          "high": 99
        },
        "interpretation": "N",
        "panel": {
          "code": "24323-8",
          "display": "Comprehensive metabolic 2000 panel - Serum or Plasma"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2345-7",
            "display": "Glucose [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0006"
          ],
          "synthetic_reason": "Synthetic chemistry at presentation; normal liver tests.",
          "author": "The Human Record generator",
          "created": "2026-11-05T10:00:00-05:00"
        }
      },
      {
        "id": "OBS-ALT-V1",
        "display": "Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
        "label": "ALT",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-03-16",
        "value": 18,
        "unit": "U/L",
        "reference_range": {
          "low": 7,
          "high": 35
        },
        "interpretation": "N",
        "panel": {
          "code": "24323-8",
          "display": "Comprehensive metabolic 2000 panel - Serum or Plasma"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "1742-6",
            "display": "Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0006"
          ],
          "synthetic_reason": "Synthetic chemistry at presentation; normal liver tests.",
          "author": "The Human Record generator",
          "created": "2026-11-05T10:00:00-05:00"
        }
      },
      {
        "id": "OBS-AST-V1",
        "display": "Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
        "label": "AST",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-03-16",
        "value": 21,
        "unit": "U/L",
        "reference_range": {
          "low": 8,
          "high": 35
        },
        "interpretation": "N",
        "panel": {
          "code": "24323-8",
          "display": "Comprehensive metabolic 2000 panel - Serum or Plasma"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "1920-8",
            "display": "Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0006"
          ],
          "synthetic_reason": "Synthetic chemistry at presentation; normal liver tests.",
          "author": "The Human Record generator",
          "created": "2026-11-05T10:00:00-05:00"
        }
      },
      {
        "id": "OBS-ALP-V1",
        "display": "Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma",
        "label": "Alkaline phosphatase",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-03-16",
        "value": 72,
        "unit": "U/L",
        "reference_range": {
          "low": 35,
          "high": 104
        },
        "interpretation": "N",
        "panel": {
          "code": "24323-8",
          "display": "Comprehensive metabolic 2000 panel - Serum or Plasma"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "6768-6",
            "display": "Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0006"
          ],
          "synthetic_reason": "Synthetic chemistry at presentation; normal liver tests.",
          "author": "The Human Record generator",
          "created": "2026-11-05T10:00:00-05:00"
        }
      },
      {
        "id": "OBS-TBIL-V1",
        "display": "Bilirubin.total [Mass/volume] in Serum or Plasma",
        "label": "Total bilirubin",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-03-16",
        "value": 0.6,
        "unit": "mg/dL",
        "reference_range": {
          "low": 0.1,
          "high": 1.2
        },
        "interpretation": "N",
        "panel": {
          "code": "24323-8",
          "display": "Comprehensive metabolic 2000 panel - Serum or Plasma"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "1975-2",
            "display": "Bilirubin.total [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0006"
          ],
          "synthetic_reason": "Synthetic chemistry at presentation; normal liver tests.",
          "author": "The Human Record generator",
          "created": "2026-11-05T10:00:00-05:00"
        }
      },
      {
        "id": "OBS-ALB-V1",
        "display": "Albumin [Mass/volume] in Serum or Plasma",
        "label": "Albumin",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-03-16",
        "value": 4.3,
        "unit": "g/dL",
        "reference_range": {
          "low": 3.5,
          "high": 5.0
        },
        "interpretation": "N",
        "panel": {
          "code": "24323-8",
          "display": "Comprehensive metabolic 2000 panel - Serum or Plasma"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "1751-7",
            "display": "Albumin [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0006"
          ],
          "synthetic_reason": "Synthetic chemistry at presentation; normal liver tests.",
          "author": "The Human Record generator",
          "created": "2026-11-05T10:00:00-05:00"
        }
      },
      {
        "id": "OBS-CEA-V1",
        "display": "Carcinoembryonic Ag [Mass/volume] in Serum or Plasma",
        "label": "CEA",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-03-16",
        "value": 5.8,
        "unit": "ng/mL",
        "reference_range": {
          "high": 3.0,
          "text": "Up to 3.0 ng/mL in non-smokers"
        },
        "interpretation": "H",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2039-6",
            "display": "Carcinoembryonic Ag [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0006"
          ],
          "synthetic_reason": "Synthetic CEA at presentation, drawn because a rectal mass was felt; a raised value is not diagnostic.",
          "author": "The Human Record generator",
          "created": "2026-11-05T10:00:00-05:00"
        }
      },
      {
        "id": "OBS-PHQ2-V1",
        "display": "Patient Health Questionnaire 2 item (PHQ-2) total score [Reported]",
        "label": "PHQ-2",
        "status": "final",
        "effective_date": "2026-03-16",
        "value": 1,
        "unit": "{score}",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "55758-7",
            "display": "Patient Health Questionnaire 2 item (PHQ-2) total score [Reported]",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic depression screen; negative. Not a claim about her real mood.",
          "author": "The Human Record generator",
          "created": "2026-11-05T10:00:00-05:00"
        }
      },
      {
        "id": "OBS-HGB-V2",
        "display": "Hemoglobin [Mass/volume] in Blood",
        "label": "Hemoglobin",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-03-30",
        "value": 11.1,
        "unit": "g/dL",
        "reference_range": {
          "low": 12.0,
          "high": 15.5
        },
        "interpretation": "L",
        "panel": {
          "code": "58410-2",
          "display": "CBC panel - Blood by Automated count"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "718-7",
            "display": "Hemoglobin [Mass/volume] in Blood",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007",
            "CLM-0012"
          ],
          "synthetic_reason": "Synthetic blood count before treatment.",
          "author": "The Human Record generator",
          "created": "2026-11-05T10:00:00-05:00"
        }
      },
      {
        "id": "OBS-WBC-V2",
        "display": "Leukocytes [#/volume] in Blood by Automated count",
        "label": "White cell count",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-03-30",
        "value": 6.5,
        "unit": "10*3/uL",
        "reference_range": {
          "low": 4.0,
          "high": 11.0
        },
        "interpretation": "N",
        "panel": {
          "code": "58410-2",
          "display": "CBC panel - Blood by Automated count"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "6690-2",
            "display": "Leukocytes [#/volume] in Blood by Automated count",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007",
            "CLM-0012"
          ],
          "synthetic_reason": "Synthetic blood count before treatment.",
          "author": "The Human Record generator",
          "created": "2026-11-05T10:00:00-05:00"
        }
      },
      {
        "id": "OBS-PLT-V2",
        "display": "Platelets [#/volume] in Blood by Automated count",
        "label": "Platelets",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-03-30",
        "value": 405,
        "unit": "10*3/uL",
        "reference_range": {
          "low": 150,
          "high": 400
        },
        "interpretation": "H",
        "panel": {
          "code": "58410-2",
          "display": "CBC panel - Blood by Automated count"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "777-3",
            "display": "Platelets [#/volume] in Blood by Automated count",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007",
            "CLM-0012"
          ],
          "synthetic_reason": "Synthetic blood count before treatment.",
          "author": "The Human Record generator",
          "created": "2026-11-05T10:00:00-05:00"
        }
      },
      {
        "id": "OBS-CR-V2",
        "display": "Creatinine [Mass/volume] in Serum or Plasma",
        "label": "Creatinine",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-03-30",
        "value": 0.76,
        "unit": "mg/dL",
        "reference_range": {
          "low": 0.59,
          "high": 1.04
        },
        "interpretation": "N",
        "panel": {
          "code": "24323-8",
          "display": "Comprehensive metabolic 2000 panel - Serum or Plasma"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2160-0",
            "display": "Creatinine [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007",
            "CLM-0012"
          ],
          "synthetic_reason": "Synthetic baseline chemistry before PD-1 blockade.",
          "author": "The Human Record generator",
          "created": "2026-11-05T10:00:00-05:00"
        }
      },
      {
        "id": "OBS-EGFR-V2",
        "display": "Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M",
        "label": "eGFR (CKD-EPI 2021)",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-03-30",
        "value": 101,
        "unit": "mL/min/{1.73_m2}",
        "reference_range": {
          "low": 60
        },
        "interpretation": "N",
        "panel": {
          "code": "24323-8",
          "display": "Comprehensive metabolic 2000 panel - Serum or Plasma"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "98979-8",
            "display": "Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007",
            "CLM-0012"
          ],
          "synthetic_reason": "Synthetic baseline chemistry before PD-1 blockade.",
          "author": "The Human Record generator",
          "created": "2026-11-05T10:00:00-05:00"
        }
      },
      {
        "id": "OBS-GLU-V2",
        "display": "Glucose [Mass/volume] in Serum or Plasma",
        "label": "Glucose",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-03-30",
        "value": 90,
        "unit": "mg/dL",
        "reference_range": {
          "low": 70,
          "high": 99
        },
        "interpretation": "N",
        "panel": {
          "code": "24323-8",
          "display": "Comprehensive metabolic 2000 panel - Serum or Plasma"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2345-7",
            "display": "Glucose [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007",
            "CLM-0012"
          ],
          "synthetic_reason": "Synthetic baseline chemistry before PD-1 blockade.",
          "author": "The Human Record generator",
          "created": "2026-11-05T10:00:00-05:00"
        }
      },
      {
        "id": "OBS-ALT-V2",
        "display": "Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
        "label": "ALT",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-03-30",
        "value": 17,
        "unit": "U/L",
        "reference_range": {
          "low": 7,
          "high": 35
        },
        "interpretation": "N",
        "panel": {
          "code": "24323-8",
          "display": "Comprehensive metabolic 2000 panel - Serum or Plasma"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "1742-6",
            "display": "Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007",
            "CLM-0012"
          ],
          "synthetic_reason": "Synthetic baseline chemistry before PD-1 blockade.",
          "author": "The Human Record generator",
          "created": "2026-11-05T10:00:00-05:00"
        }
      },
      {
        "id": "OBS-AST-V2",
        "display": "Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
        "label": "AST",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-03-30",
        "value": 20,
        "unit": "U/L",
        "reference_range": {
          "low": 8,
          "high": 35
        },
        "interpretation": "N",
        "panel": {
          "code": "24323-8",
          "display": "Comprehensive metabolic 2000 panel - Serum or Plasma"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "1920-8",
            "display": "Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007",
            "CLM-0012"
          ],
          "synthetic_reason": "Synthetic baseline chemistry before PD-1 blockade.",
          "author": "The Human Record generator",
          "created": "2026-11-05T10:00:00-05:00"
        }
      },
      {
        "id": "OBS-TSH-V2",
        "display": "Thyrotropin [Units/volume] in Serum or Plasma",
        "label": "TSH",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-03-30",
        "value": 1.9,
        "unit": "m[IU]/L",
        "reference_range": {
          "low": 0.45,
          "high": 4.5
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "3016-3",
            "display": "Thyrotropin [Units/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007",
            "CLM-0012"
          ],
          "synthetic_reason": "Synthetic baseline TSH before PD-1 blockade.",
          "author": "The Human Record generator",
          "created": "2026-11-05T10:00:00-05:00"
        }
      },
      {
        "id": "OBS-FT4-V2",
        "display": "Thyroxine (T4) free [Mass/volume] in Serum or Plasma",
        "label": "Free T4",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-03-30",
        "value": 1.2,
        "unit": "ng/dL",
        "reference_range": {
          "low": 0.8,
          "high": 1.8
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "3024-7",
            "display": "Thyroxine (T4) free [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007",
            "CLM-0012"
          ],
          "synthetic_reason": "Synthetic baseline free T4 before PD-1 blockade.",
          "author": "The Human Record generator",
          "created": "2026-11-05T10:00:00-05:00"
        }
      },
      {
        "id": "OBS-PHQ9-V2",
        "display": "Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]",
        "label": "PHQ-9",
        "status": "final",
        "effective_date": "2026-03-30",
        "value": 6,
        "unit": "{score}",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "44261-6",
            "display": "Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic PHQ-9 on the day the diagnosis was explained; item 9 scored 0. Not a claim about her real mood.",
          "author": "The Human Record generator",
          "created": "2026-11-05T10:00:00-05:00"
        }
      },
      {
        "id": "OBS-GAD7-V2",
        "display": "Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ]",
        "label": "GAD-7",
        "status": "final",
        "effective_date": "2026-03-30",
        "value": 7,
        "unit": "{score}",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "70274-6",
            "display": "Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ]",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic GAD-7 on the day of the diagnosis.",
          "author": "The Human Record generator",
          "created": "2026-11-05T10:00:00-05:00"
        }
      },
      {
        "id": "OBS-HGB-V3",
        "display": "Hemoglobin [Mass/volume] in Blood",
        "label": "Hemoglobin",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-04-27",
        "value": 12.1,
        "unit": "g/dL",
        "reference_range": {
          "low": 12.0,
          "high": 15.5
        },
        "interpretation": "N",
        "panel": {
          "code": "58410-2",
          "display": "CBC panel - Blood by Automated count"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "718-7",
            "display": "Hemoglobin [Mass/volume] in Blood",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007",
            "CLM-0012"
          ],
          "synthetic_reason": "Synthetic blood count four weeks after oral iron began.",
          "author": "The Human Record generator",
          "created": "2026-11-05T10:00:00-05:00"
        }
      },
      {
        "id": "OBS-MCV-V3",
        "display": "MCV [Entitic mean volume] in Red Blood Cells by Automated count",
        "label": "MCV",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-04-27",
        "value": 80,
        "unit": "fL",
        "reference_range": {
          "low": 80,
          "high": 100
        },
        "interpretation": "N",
        "panel": {
          "code": "58410-2",
          "display": "CBC panel - Blood by Automated count"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "787-2",
            "display": "MCV [Entitic mean volume] in Red Blood Cells by Automated count",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007",
            "CLM-0012"
          ],
          "synthetic_reason": "Synthetic blood count four weeks after oral iron began.",
          "author": "The Human Record generator",
          "created": "2026-11-05T10:00:00-05:00"
        }
      },
      {
        "id": "OBS-WBC-V3",
        "display": "Leukocytes [#/volume] in Blood by Automated count",
        "label": "White cell count",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-04-27",
        "value": 6.2,
        "unit": "10*3/uL",
        "reference_range": {
          "low": 4.0,
          "high": 11.0
        },
        "interpretation": "N",
        "panel": {
          "code": "58410-2",
          "display": "CBC panel - Blood by Automated count"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "6690-2",
            "display": "Leukocytes [#/volume] in Blood by Automated count",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007",
            "CLM-0012"
          ],
          "synthetic_reason": "Synthetic blood count four weeks after oral iron began.",
          "author": "The Human Record generator",
          "created": "2026-11-05T10:00:00-05:00"
        }
      },
      {
        "id": "OBS-PLT-V3",
        "display": "Platelets [#/volume] in Blood by Automated count",
        "label": "Platelets",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-04-27",
        "value": 352,
        "unit": "10*3/uL",
        "reference_range": {
          "low": 150,
          "high": 400
        },
        "interpretation": "N",
        "panel": {
          "code": "58410-2",
          "display": "CBC panel - Blood by Automated count"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "777-3",
            "display": "Platelets [#/volume] in Blood by Automated count",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007",
            "CLM-0012"
          ],
          "synthetic_reason": "Synthetic blood count four weeks after oral iron began.",
          "author": "The Human Record generator",
          "created": "2026-11-05T10:00:00-05:00"
        }
      },
      {
        "id": "OBS-CR-V3",
        "display": "Creatinine [Mass/volume] in Serum or Plasma",
        "label": "Creatinine",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-04-27",
        "value": 0.74,
        "unit": "mg/dL",
        "reference_range": {
          "low": 0.59,
          "high": 1.04
        },
        "interpretation": "N",
        "panel": {
          "code": "24323-8",
          "display": "Comprehensive metabolic 2000 panel - Serum or Plasma"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2160-0",
            "display": "Creatinine [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007",
            "CLM-0012"
          ],
          "synthetic_reason": "Synthetic chemistry before cycle 2.",
          "author": "The Human Record generator",
          "created": "2026-11-05T10:00:00-05:00"
        }
      },
      {
        "id": "OBS-EGFR-V3",
        "display": "Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M",
        "label": "eGFR (CKD-EPI 2021)",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-04-27",
        "value": 104,
        "unit": "mL/min/{1.73_m2}",
        "reference_range": {
          "low": 60
        },
        "interpretation": "N",
        "panel": {
          "code": "24323-8",
          "display": "Comprehensive metabolic 2000 panel - Serum or Plasma"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "98979-8",
            "display": "Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007",
            "CLM-0012"
          ],
          "synthetic_reason": "Synthetic chemistry before cycle 2.",
          "author": "The Human Record generator",
          "created": "2026-11-05T10:00:00-05:00"
        }
      },
      {
        "id": "OBS-GLU-V3",
        "display": "Glucose [Mass/volume] in Serum or Plasma",
        "label": "Glucose",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-04-27",
        "value": 92,
        "unit": "mg/dL",
        "reference_range": {
          "low": 70,
          "high": 99
        },
        "interpretation": "N",
        "panel": {
          "code": "24323-8",
          "display": "Comprehensive metabolic 2000 panel - Serum or Plasma"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2345-7",
            "display": "Glucose [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007",
            "CLM-0012"
          ],
          "synthetic_reason": "Synthetic chemistry before cycle 2.",
          "author": "The Human Record generator",
          "created": "2026-11-05T10:00:00-05:00"
        }
      },
      {
        "id": "OBS-ALT-V3",
        "display": "Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
        "label": "ALT",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-04-27",
        "value": 22,
        "unit": "U/L",
        "reference_range": {
          "low": 7,
          "high": 35
        },
        "interpretation": "N",
        "panel": {
          "code": "24323-8",
          "display": "Comprehensive metabolic 2000 panel - Serum or Plasma"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "1742-6",
            "display": "Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007",
            "CLM-0012"
          ],
          "synthetic_reason": "Synthetic chemistry before cycle 2.",
          "author": "The Human Record generator",
          "created": "2026-11-05T10:00:00-05:00"
        }
      },
      {
        "id": "OBS-AST-V3",
        "display": "Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
        "label": "AST",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-04-27",
        "value": 24,
        "unit": "U/L",
        "reference_range": {
          "low": 8,
          "high": 35
        },
        "interpretation": "N",
        "panel": {
          "code": "24323-8",
          "display": "Comprehensive metabolic 2000 panel - Serum or Plasma"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "1920-8",
            "display": "Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007",
            "CLM-0012"
          ],
          "synthetic_reason": "Synthetic chemistry before cycle 2.",
          "author": "The Human Record generator",
          "created": "2026-11-05T10:00:00-05:00"
        }
      },
      {
        "id": "OBS-TSH-V3",
        "display": "Thyrotropin [Units/volume] in Serum or Plasma",
        "label": "TSH",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-04-27",
        "value": 2.2,
        "unit": "m[IU]/L",
        "reference_range": {
          "low": 0.45,
          "high": 4.5
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "3016-3",
            "display": "Thyrotropin [Units/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007",
            "CLM-0012"
          ],
          "synthetic_reason": "Synthetic TSH before cycle 2.",
          "author": "The Human Record generator",
          "created": "2026-11-05T10:00:00-05:00"
        }
      },
      {
        "id": "OBS-FT4-V3",
        "display": "Thyroxine (T4) free [Mass/volume] in Serum or Plasma",
        "label": "Free T4",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-04-27",
        "value": 1.2,
        "unit": "ng/dL",
        "reference_range": {
          "low": 0.8,
          "high": 1.8
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "3024-7",
            "display": "Thyroxine (T4) free [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007",
            "CLM-0012"
          ],
          "synthetic_reason": "Synthetic free T4 before cycle 2.",
          "author": "The Human Record generator",
          "created": "2026-11-05T10:00:00-05:00"
        }
      },
      {
        "id": "OBS-CEA-V3",
        "display": "Carcinoembryonic Ag [Mass/volume] in Serum or Plasma",
        "label": "CEA",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-04-27",
        "value": 3.4,
        "unit": "ng/mL",
        "reference_range": {
          "high": 3.0,
          "text": "Up to 3.0 ng/mL in non-smokers"
        },
        "interpretation": "H",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2039-6",
            "display": "Carcinoembryonic Ag [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007",
            "CLM-0012"
          ],
          "synthetic_reason": "Synthetic CEA three weeks after the first dose; falling.",
          "author": "The Human Record generator",
          "created": "2026-11-05T10:00:00-05:00"
        }
      },
      {
        "id": "OBS-PHQ9-V3",
        "display": "Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]",
        "label": "PHQ-9",
        "status": "final",
        "effective_date": "2026-04-27",
        "value": 4,
        "unit": "{score}",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "44261-6",
            "display": "Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic PHQ-9; item 9 scored 0.",
          "author": "The Human Record generator",
          "created": "2026-11-05T10:00:00-05:00"
        }
      },
      {
        "id": "OBS-HGB-V6",
        "display": "Hemoglobin [Mass/volume] in Blood",
        "label": "Hemoglobin",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-06-01",
        "value": 12.6,
        "unit": "g/dL",
        "reference_range": {
          "low": 12.0,
          "high": 15.5
        },
        "interpretation": "N",
        "panel": {
          "code": "58410-2",
          "display": "CBC panel - Blood by Automated count"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "718-7",
            "display": "Hemoglobin [Mass/volume] in Blood",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007",
            "CLM-0012"
          ],
          "synthetic_reason": "Synthetic blood count at the sick visit.",
          "author": "The Human Record generator",
          "created": "2026-11-05T10:00:00-05:00"
        }
      },
      {
        "id": "OBS-WBC-V6",
        "display": "Leukocytes [#/volume] in Blood by Automated count",
        "label": "White cell count",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-06-01",
        "value": 9.4,
        "unit": "10*3/uL",
        "reference_range": {
          "low": 4.0,
          "high": 11.0
        },
        "interpretation": "N",
        "panel": {
          "code": "58410-2",
          "display": "CBC panel - Blood by Automated count"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "6690-2",
            "display": "Leukocytes [#/volume] in Blood by Automated count",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007",
            "CLM-0012"
          ],
          "synthetic_reason": "Synthetic blood count at the sick visit.",
          "author": "The Human Record generator",
          "created": "2026-11-05T10:00:00-05:00"
        }
      },
      {
        "id": "OBS-PLT-V6",
        "display": "Platelets [#/volume] in Blood by Automated count",
        "label": "Platelets",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-06-01",
        "value": 290,
        "unit": "10*3/uL",
        "reference_range": {
          "low": 150,
          "high": 400
        },
        "interpretation": "N",
        "panel": {
          "code": "58410-2",
          "display": "CBC panel - Blood by Automated count"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "777-3",
            "display": "Platelets [#/volume] in Blood by Automated count",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007",
            "CLM-0012"
          ],
          "synthetic_reason": "Synthetic blood count at the sick visit.",
          "author": "The Human Record generator",
          "created": "2026-11-05T10:00:00-05:00"
        }
      },
      {
        "id": "OBS-TSH-V6",
        "display": "Thyrotropin [Units/volume] in Serum or Plasma",
        "label": "TSH",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-06-01",
        "value": 5.8,
        "unit": "m[IU]/L",
        "reference_range": {
          "low": 0.45,
          "high": 4.5
        },
        "interpretation": "H",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "3016-3",
            "display": "Thyrotropin [Units/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007",
            "CLM-0012"
          ],
          "synthetic_reason": "Synthetic TSH at the sick visit, drawn because of tiredness on PD-1 blockade; mildly raised with a normal free T4.",
          "author": "The Human Record generator",
          "created": "2026-11-05T10:00:00-05:00"
        }
      },
      {
        "id": "OBS-FT4-V6",
        "display": "Thyroxine (T4) free [Mass/volume] in Serum or Plasma",
        "label": "Free T4",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-06-01",
        "value": 1.0,
        "unit": "ng/dL",
        "reference_range": {
          "low": 0.8,
          "high": 1.8
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "3024-7",
            "display": "Thyroxine (T4) free [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007",
            "CLM-0012"
          ],
          "synthetic_reason": "Synthetic free T4 at the sick visit; normal.",
          "author": "The Human Record generator",
          "created": "2026-11-05T10:00:00-05:00"
        }
      },
      {
        "id": "OBS-HGB-V4",
        "display": "Hemoglobin [Mass/volume] in Blood",
        "label": "Hemoglobin",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-06-29",
        "value": 13.0,
        "unit": "g/dL",
        "reference_range": {
          "low": 12.0,
          "high": 15.5
        },
        "interpretation": "N",
        "panel": {
          "code": "58410-2",
          "display": "CBC panel - Blood by Automated count"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "718-7",
            "display": "Hemoglobin [Mass/volume] in Blood",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007",
            "CLM-0012"
          ],
          "synthetic_reason": "Synthetic blood count before cycle 5.",
          "author": "The Human Record generator",
          "created": "2026-11-05T10:00:00-05:00"
        }
      },
      {
        "id": "OBS-WBC-V4",
        "display": "Leukocytes [#/volume] in Blood by Automated count",
        "label": "White cell count",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-06-29",
        "value": 6.0,
        "unit": "10*3/uL",
        "reference_range": {
          "low": 4.0,
          "high": 11.0
        },
        "interpretation": "N",
        "panel": {
          "code": "58410-2",
          "display": "CBC panel - Blood by Automated count"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "6690-2",
            "display": "Leukocytes [#/volume] in Blood by Automated count",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007",
            "CLM-0012"
          ],
          "synthetic_reason": "Synthetic blood count before cycle 5.",
          "author": "The Human Record generator",
          "created": "2026-11-05T10:00:00-05:00"
        }
      },
      {
        "id": "OBS-PLT-V4",
        "display": "Platelets [#/volume] in Blood by Automated count",
        "label": "Platelets",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-06-29",
        "value": 268,
        "unit": "10*3/uL",
        "reference_range": {
          "low": 150,
          "high": 400
        },
        "interpretation": "N",
        "panel": {
          "code": "58410-2",
          "display": "CBC panel - Blood by Automated count"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "777-3",
            "display": "Platelets [#/volume] in Blood by Automated count",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007",
            "CLM-0012"
          ],
          "synthetic_reason": "Synthetic blood count before cycle 5.",
          "author": "The Human Record generator",
          "created": "2026-11-05T10:00:00-05:00"
        }
      },
      {
        "id": "OBS-NA-V4",
        "display": "Sodium [Moles/volume] in Serum or Plasma",
        "label": "Sodium",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-06-29",
        "value": 140,
        "unit": "mmol/L",
        "reference_range": {
          "low": 135,
          "high": 145
        },
        "interpretation": "N",
        "panel": {
          "code": "24323-8",
          "display": "Comprehensive metabolic 2000 panel - Serum or Plasma"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2951-2",
            "display": "Sodium [Moles/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007",
            "CLM-0012"
          ],
          "synthetic_reason": "Synthetic chemistry before cycle 5.",
          "author": "The Human Record generator",
          "created": "2026-11-05T10:00:00-05:00"
        }
      },
      {
        "id": "OBS-K-V4",
        "display": "Potassium [Moles/volume] in Serum or Plasma",
        "label": "Potassium",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-06-29",
        "value": 4.2,
        "unit": "mmol/L",
        "reference_range": {
          "low": 3.5,
          "high": 5.1
        },
        "interpretation": "N",
        "panel": {
          "code": "24323-8",
          "display": "Comprehensive metabolic 2000 panel - Serum or Plasma"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2823-3",
            "display": "Potassium [Moles/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007",
            "CLM-0012"
          ],
          "synthetic_reason": "Synthetic chemistry before cycle 5.",
          "author": "The Human Record generator",
          "created": "2026-11-05T10:00:00-05:00"
        }
      },
      {
        "id": "OBS-CR-V4",
        "display": "Creatinine [Mass/volume] in Serum or Plasma",
        "label": "Creatinine",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-06-29",
        "value": 0.75,
        "unit": "mg/dL",
        "reference_range": {
          "low": 0.59,
          "high": 1.04
        },
        "interpretation": "N",
        "panel": {
          "code": "24323-8",
          "display": "Comprehensive metabolic 2000 panel - Serum or Plasma"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2160-0",
            "display": "Creatinine [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007",
            "CLM-0012"
          ],
          "synthetic_reason": "Synthetic chemistry before cycle 5.",
          "author": "The Human Record generator",
          "created": "2026-11-05T10:00:00-05:00"
        }
      },
      {
        "id": "OBS-EGFR-V4",
        "display": "Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M",
        "label": "eGFR (CKD-EPI 2021)",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-06-29",
        "value": 102,
        "unit": "mL/min/{1.73_m2}",
        "reference_range": {
          "low": 60
        },
        "interpretation": "N",
        "panel": {
          "code": "24323-8",
          "display": "Comprehensive metabolic 2000 panel - Serum or Plasma"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "98979-8",
            "display": "Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007",
            "CLM-0012"
          ],
          "synthetic_reason": "Synthetic chemistry before cycle 5.",
          "author": "The Human Record generator",
          "created": "2026-11-05T10:00:00-05:00"
        }
      },
      {
        "id": "OBS-GLU-V4",
        "display": "Glucose [Mass/volume] in Serum or Plasma",
        "label": "Glucose",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-06-29",
        "value": 89,
        "unit": "mg/dL",
        "reference_range": {
          "low": 70,
          "high": 99
        },
        "interpretation": "N",
        "panel": {
          "code": "24323-8",
          "display": "Comprehensive metabolic 2000 panel - Serum or Plasma"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2345-7",
            "display": "Glucose [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007",
            "CLM-0012"
          ],
          "synthetic_reason": "Synthetic chemistry before cycle 5.",
          "author": "The Human Record generator",
          "created": "2026-11-05T10:00:00-05:00"
        }
      },
      {
        "id": "OBS-ALT-V4",
        "display": "Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
        "label": "ALT",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-06-29",
        "value": 20,
        "unit": "U/L",
        "reference_range": {
          "low": 7,
          "high": 35
        },
        "interpretation": "N",
        "panel": {
          "code": "24323-8",
          "display": "Comprehensive metabolic 2000 panel - Serum or Plasma"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "1742-6",
            "display": "Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007",
            "CLM-0012"
          ],
          "synthetic_reason": "Synthetic chemistry before cycle 5.",
          "author": "The Human Record generator",
          "created": "2026-11-05T10:00:00-05:00"
        }
      },
      {
        "id": "OBS-AST-V4",
        "display": "Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
        "label": "AST",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-06-29",
        "value": 22,
        "unit": "U/L",
        "reference_range": {
          "low": 8,
          "high": 35
        },
        "interpretation": "N",
        "panel": {
          "code": "24323-8",
          "display": "Comprehensive metabolic 2000 panel - Serum or Plasma"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "1920-8",
            "display": "Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007",
            "CLM-0012"
          ],
          "synthetic_reason": "Synthetic chemistry before cycle 5.",
          "author": "The Human Record generator",
          "created": "2026-11-05T10:00:00-05:00"
        }
      },
      {
        "id": "OBS-ALP-V4",
        "display": "Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma",
        "label": "Alkaline phosphatase",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-06-29",
        "value": 70,
        "unit": "U/L",
        "reference_range": {
          "low": 35,
          "high": 104
        },
        "interpretation": "N",
        "panel": {
          "code": "24323-8",
          "display": "Comprehensive metabolic 2000 panel - Serum or Plasma"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "6768-6",
            "display": "Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007",
            "CLM-0012"
          ],
          "synthetic_reason": "Synthetic chemistry before cycle 5.",
          "author": "The Human Record generator",
          "created": "2026-11-05T10:00:00-05:00"
        }
      },
      {
        "id": "OBS-TBIL-V4",
        "display": "Bilirubin.total [Mass/volume] in Serum or Plasma",
        "label": "Total bilirubin",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-06-29",
        "value": 0.5,
        "unit": "mg/dL",
        "reference_range": {
          "low": 0.1,
          "high": 1.2
        },
        "interpretation": "N",
        "panel": {
          "code": "24323-8",
          "display": "Comprehensive metabolic 2000 panel - Serum or Plasma"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "1975-2",
            "display": "Bilirubin.total [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007",
            "CLM-0012"
          ],
          "synthetic_reason": "Synthetic chemistry before cycle 5.",
          "author": "The Human Record generator",
          "created": "2026-11-05T10:00:00-05:00"
        }
      },
      {
        "id": "OBS-ALB-V4",
        "display": "Albumin [Mass/volume] in Serum or Plasma",
        "label": "Albumin",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-06-29",
        "value": 4.4,
        "unit": "g/dL",
        "reference_range": {
          "low": 3.5,
          "high": 5.0
        },
        "interpretation": "N",
        "panel": {
          "code": "24323-8",
          "display": "Comprehensive metabolic 2000 panel - Serum or Plasma"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "1751-7",
            "display": "Albumin [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007",
            "CLM-0012"
          ],
          "synthetic_reason": "Synthetic chemistry before cycle 5.",
          "author": "The Human Record generator",
          "created": "2026-11-05T10:00:00-05:00"
        }
      },
      {
        "id": "OBS-TSH-V4",
        "display": "Thyrotropin [Units/volume] in Serum or Plasma",
        "label": "TSH",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-06-29",
        "value": 12.6,
        "unit": "m[IU]/L",
        "reference_range": {
          "low": 0.45,
          "high": 4.5
        },
        "interpretation": "H",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "3016-3",
            "display": "Thyrotropin [Units/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007",
            "CLM-0012"
          ],
          "synthetic_reason": "Synthetic TSH: immune-related hypothyroidism.",
          "author": "The Human Record generator",
          "created": "2026-11-05T10:00:00-05:00"
        }
      },
      {
        "id": "OBS-FT4-V4",
        "display": "Thyroxine (T4) free [Mass/volume] in Serum or Plasma",
        "label": "Free T4",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-06-29",
        "value": 0.6,
        "unit": "ng/dL",
        "reference_range": {
          "low": 0.8,
          "high": 1.8
        },
        "interpretation": "L",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "3024-7",
            "display": "Thyroxine (T4) free [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007",
            "CLM-0012"
          ],
          "synthetic_reason": "Synthetic free T4: low.",
          "author": "The Human Record generator",
          "created": "2026-11-05T10:00:00-05:00"
        }
      },
      {
        "id": "OBS-CEA-V4",
        "display": "Carcinoembryonic Ag [Mass/volume] in Serum or Plasma",
        "label": "CEA",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-06-29",
        "value": 2.1,
        "unit": "ng/mL",
        "reference_range": {
          "high": 3.0,
          "text": "Up to 3.0 ng/mL in non-smokers"
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2039-6",
            "display": "Carcinoembryonic Ag [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007",
            "CLM-0012"
          ],
          "synthetic_reason": "Synthetic CEA after four doses; normal.",
          "author": "The Human Record generator",
          "created": "2026-11-05T10:00:00-05:00"
        }
      },
      {
        "id": "OBS-PHQ9-V4",
        "display": "Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]",
        "label": "PHQ-9",
        "status": "final",
        "effective_date": "2026-06-29",
        "value": 3,
        "unit": "{score}",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "44261-6",
            "display": "Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic PHQ-9; item 9 scored 0.",
          "author": "The Human Record generator",
          "created": "2026-11-05T10:00:00-05:00"
        }
      },
      {
        "id": "OBS-TSH-V7",
        "display": "Thyrotropin [Units/volume] in Serum or Plasma",
        "label": "TSH",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-08-10",
        "value": 3.1,
        "unit": "m[IU]/L",
        "reference_range": {
          "low": 0.45,
          "high": 4.5
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "3016-3",
            "display": "Thyrotropin [Units/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007",
            "CLM-0012"
          ],
          "synthetic_reason": "Synthetic TSH six weeks after levothyroxine began.",
          "author": "The Human Record generator",
          "created": "2026-11-05T10:00:00-05:00"
        }
      },
      {
        "id": "OBS-FT4-V7",
        "display": "Thyroxine (T4) free [Mass/volume] in Serum or Plasma",
        "label": "Free T4",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-08-10",
        "value": 1.1,
        "unit": "ng/dL",
        "reference_range": {
          "low": 0.8,
          "high": 1.8
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "3024-7",
            "display": "Thyroxine (T4) free [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007",
            "CLM-0012"
          ],
          "synthetic_reason": "Synthetic free T4 six weeks after levothyroxine began.",
          "author": "The Human Record generator",
          "created": "2026-11-05T10:00:00-05:00"
        }
      },
      {
        "id": "OBS-PHQ9-V7",
        "display": "Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]",
        "label": "PHQ-9",
        "status": "final",
        "effective_date": "2026-08-10",
        "value": 2,
        "unit": "{score}",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "44261-6",
            "display": "Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic PHQ-9 at the preventive visit; item 9 scored 0. Not a claim about her real mood.",
          "author": "The Human Record generator",
          "created": "2026-11-05T10:00:00-05:00"
        }
      },
      {
        "id": "OBS-HGB-V5",
        "display": "Hemoglobin [Mass/volume] in Blood",
        "label": "Hemoglobin",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-10-05",
        "value": 13.4,
        "unit": "g/dL",
        "reference_range": {
          "low": 12.0,
          "high": 15.5
        },
        "interpretation": "N",
        "panel": {
          "code": "58410-2",
          "display": "CBC panel - Blood by Automated count"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "718-7",
            "display": "Hemoglobin [Mass/volume] in Blood",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007",
            "CLM-0012"
          ],
          "synthetic_reason": "Synthetic blood count after treatment.",
          "author": "The Human Record generator",
          "created": "2026-11-05T10:00:00-05:00"
        }
      },
      {
        "id": "OBS-MCV-V5",
        "display": "MCV [Entitic mean volume] in Red Blood Cells by Automated count",
        "label": "MCV",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-10-05",
        "value": 86,
        "unit": "fL",
        "reference_range": {
          "low": 80,
          "high": 100
        },
        "interpretation": "N",
        "panel": {
          "code": "58410-2",
          "display": "CBC panel - Blood by Automated count"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "787-2",
            "display": "MCV [Entitic mean volume] in Red Blood Cells by Automated count",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007",
            "CLM-0012"
          ],
          "synthetic_reason": "Synthetic blood count after treatment.",
          "author": "The Human Record generator",
          "created": "2026-11-05T10:00:00-05:00"
        }
      },
      {
        "id": "OBS-WBC-V5",
        "display": "Leukocytes [#/volume] in Blood by Automated count",
        "label": "White cell count",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-10-05",
        "value": 6.1,
        "unit": "10*3/uL",
        "reference_range": {
          "low": 4.0,
          "high": 11.0
        },
        "interpretation": "N",
        "panel": {
          "code": "58410-2",
          "display": "CBC panel - Blood by Automated count"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "6690-2",
            "display": "Leukocytes [#/volume] in Blood by Automated count",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007",
            "CLM-0012"
          ],
          "synthetic_reason": "Synthetic blood count after treatment.",
          "author": "The Human Record generator",
          "created": "2026-11-05T10:00:00-05:00"
        }
      },
      {
        "id": "OBS-PLT-V5",
        "display": "Platelets [#/volume] in Blood by Automated count",
        "label": "Platelets",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-10-05",
        "value": 255,
        "unit": "10*3/uL",
        "reference_range": {
          "low": 150,
          "high": 400
        },
        "interpretation": "N",
        "panel": {
          "code": "58410-2",
          "display": "CBC panel - Blood by Automated count"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "777-3",
            "display": "Platelets [#/volume] in Blood by Automated count",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007",
            "CLM-0012"
          ],
          "synthetic_reason": "Synthetic blood count after treatment.",
          "author": "The Human Record generator",
          "created": "2026-11-05T10:00:00-05:00"
        }
      },
      {
        "id": "OBS-CR-V5",
        "display": "Creatinine [Mass/volume] in Serum or Plasma",
        "label": "Creatinine",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-10-05",
        "value": 0.77,
        "unit": "mg/dL",
        "reference_range": {
          "low": 0.59,
          "high": 1.04
        },
        "interpretation": "N",
        "panel": {
          "code": "24323-8",
          "display": "Comprehensive metabolic 2000 panel - Serum or Plasma"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2160-0",
            "display": "Creatinine [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007",
            "CLM-0012"
          ],
          "synthetic_reason": "Synthetic chemistry after treatment.",
          "author": "The Human Record generator",
          "created": "2026-11-05T10:00:00-05:00"
        }
      },
      {
        "id": "OBS-EGFR-V5",
        "display": "Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M",
        "label": "eGFR (CKD-EPI 2021)",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-10-05",
        "value": 99,
        "unit": "mL/min/{1.73_m2}",
        "reference_range": {
          "low": 60
        },
        "interpretation": "N",
        "panel": {
          "code": "24323-8",
          "display": "Comprehensive metabolic 2000 panel - Serum or Plasma"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "98979-8",
            "display": "Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007",
            "CLM-0012"
          ],
          "synthetic_reason": "Synthetic chemistry after treatment.",
          "author": "The Human Record generator",
          "created": "2026-11-05T10:00:00-05:00"
        }
      },
      {
        "id": "OBS-ALT-V5",
        "display": "Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
        "label": "ALT",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-10-05",
        "value": 19,
        "unit": "U/L",
        "reference_range": {
          "low": 7,
          "high": 35
        },
        "interpretation": "N",
        "panel": {
          "code": "24323-8",
          "display": "Comprehensive metabolic 2000 panel - Serum or Plasma"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "1742-6",
            "display": "Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007",
            "CLM-0012"
          ],
          "synthetic_reason": "Synthetic chemistry after treatment.",
          "author": "The Human Record generator",
          "created": "2026-11-05T10:00:00-05:00"
        }
      },
      {
        "id": "OBS-AST-V5",
        "display": "Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
        "label": "AST",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-10-05",
        "value": 21,
        "unit": "U/L",
        "reference_range": {
          "low": 8,
          "high": 35
        },
        "interpretation": "N",
        "panel": {
          "code": "24323-8",
          "display": "Comprehensive metabolic 2000 panel - Serum or Plasma"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "1920-8",
            "display": "Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007",
            "CLM-0012"
          ],
          "synthetic_reason": "Synthetic chemistry after treatment.",
          "author": "The Human Record generator",
          "created": "2026-11-05T10:00:00-05:00"
        }
      },
      {
        "id": "OBS-FERR-V5",
        "display": "Ferritin [Mass/volume] in Serum or Plasma",
        "label": "Ferritin",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-10-05",
        "value": 41,
        "unit": "ng/mL",
        "reference_range": {
          "low": 15,
          "high": 150
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2276-4",
            "display": "Ferritin [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007",
            "CLM-0012"
          ],
          "synthetic_reason": "Synthetic ferritin after six months of oral iron (drawn late; see the deviation recorded at the fourth visit).",
          "author": "The Human Record generator",
          "created": "2026-11-05T10:00:00-05:00"
        }
      },
      {
        "id": "OBS-TSH-V5",
        "display": "Thyrotropin [Units/volume] in Serum or Plasma",
        "label": "TSH",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-10-05",
        "value": 2.4,
        "unit": "m[IU]/L",
        "reference_range": {
          "low": 0.45,
          "high": 4.5
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "3016-3",
            "display": "Thyrotropin [Units/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007",
            "CLM-0012"
          ],
          "synthetic_reason": "Synthetic TSH on levothyroxine.",
          "author": "The Human Record generator",
          "created": "2026-11-05T10:00:00-05:00"
        }
      },
      {
        "id": "OBS-FT4-V5",
        "display": "Thyroxine (T4) free [Mass/volume] in Serum or Plasma",
        "label": "Free T4",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-10-05",
        "value": 1.2,
        "unit": "ng/dL",
        "reference_range": {
          "low": 0.8,
          "high": 1.8
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "3024-7",
            "display": "Thyroxine (T4) free [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007",
            "CLM-0012"
          ],
          "synthetic_reason": "Synthetic free T4 on levothyroxine.",
          "author": "The Human Record generator",
          "created": "2026-11-05T10:00:00-05:00"
        }
      },
      {
        "id": "OBS-CEA-V5",
        "display": "Carcinoembryonic Ag [Mass/volume] in Serum or Plasma",
        "label": "CEA",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-10-05",
        "value": 1.6,
        "unit": "ng/mL",
        "reference_range": {
          "high": 3.0,
          "text": "Up to 3.0 ng/mL in non-smokers"
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2039-6",
            "display": "Carcinoembryonic Ag [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007",
            "CLM-0012"
          ],
          "synthetic_reason": "Synthetic CEA after treatment.",
          "author": "The Human Record generator",
          "created": "2026-11-05T10:00:00-05:00"
        }
      },
      {
        "id": "OBS-PHQ9-V5",
        "display": "Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]",
        "label": "PHQ-9",
        "status": "final",
        "effective_date": "2026-10-05",
        "value": 2,
        "unit": "{score}",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "44261-6",
            "display": "Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic PHQ-9; item 9 scored 0.",
          "author": "The Human Record generator",
          "created": "2026-11-05T10:00:00-05:00"
        }
      },
      {
        "id": "OBS-GAD7-V5",
        "display": "Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ]",
        "label": "GAD-7",
        "status": "final",
        "effective_date": "2026-10-05",
        "value": 3,
        "unit": "{score}",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "70274-6",
            "display": "Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ]",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic GAD-7.",
          "author": "The Human Record generator",
          "created": "2026-11-05T10:00:00-05:00"
        }
      }
    ],
    "procedures": [
      {
        "id": "PROC-001",
        "display": "Colonoscopy to the cecum with biopsy, under sedation: an ulcerated, friable mass on the posterior and left lateral wall of the lower rectum, about half the circumference, from 4 to 9 cm from the anal verge, not obstructing; six biopsies; the rest of the colon normal; no polyps. Pathology: invasive adenocarcinoma, moderately differentiated; immunohistochemistry shows loss of MSH2 and MSH6 with MLH1 and PMS2 retained; microsatellite instability high by PCR",
        "status": "completed",
        "coding": [
          {
            "system": "http://snomed.info/sct",
            "code": "446745002",
            "display": "Colonoscopy and biopsy of colon",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "period": {
          "start": "2026-03-19",
          "end": "2026-03-19"
        },
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0006"
          ],
          "synthetic_reason": "Synthetic colonoscopy three days after the first visit.",
          "author": "The Human Record generator",
          "created": "2026-11-05T10:00:00-05:00"
        }
      },
      {
        "id": "PROC-002",
        "display": "Rectal-protocol MRI of the pelvis (high-resolution T2 and diffusion-weighted): low rectal tumor, lower edge 4 cm from the anal verge and about 1 cm above the anorectal junction, posterior and left lateral, extending 4 mm beyond the muscularis propria (cT3b); two mesorectal lymph nodes of 7 mm with irregular borders (cN1); mesorectal fascia clear by 6 mm; no extramural venous invasion; no lateral pelvic nodes; sphincter complex not involved",
        "status": "completed",
        "coding": [
          {
            "system": "http://snomed.info/sct",
            "code": "2690005",
            "display": "MRI of pelvis",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "period": {
          "start": "2026-03-24",
          "end": "2026-03-24"
        },
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007",
            "CLM-0012"
          ],
          "synthetic_reason": "Synthetic staging MRI.",
          "author": "The Human Record generator",
          "created": "2026-11-05T10:00:00-05:00"
        }
      },
      {
        "id": "PROC-003",
        "display": "CT of the chest, abdomen and pelvis with contrast: no liver, lung or peritoneal metastases; no enlarged retroperitoneal nodes",
        "status": "completed",
        "coding": [
          {
            "system": "http://snomed.info/sct",
            "code": "433761009",
            "display": "CT of thorax, abdomen and pelvis with contrast",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "period": {
          "start": "2026-03-25",
          "end": "2026-03-25"
        },
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007",
            "CLM-0012"
          ],
          "synthetic_reason": "Synthetic staging CT.",
          "author": "The Human Record generator",
          "created": "2026-11-05T10:00:00-05:00"
        }
      },
      {
        "id": "PROC-004",
        "display": "Colorectal multidisciplinary tumor board (medical oncology, colorectal surgery, radiation oncology, radiology, pathology, genetics, wound-ostomy nursing, nurse navigator): mismatch repair-deficient low rectal adenocarcinoma, cT3bN1M0; surgery would most likely need an abdominoperineal resection with a permanent colostomy; recommends PD-1 blockade with dostarlimab for six months, restaging by MRI and endoscopy about every three months, and watch-and-wait if there is a clinical complete response, with chemoradiation and surgery kept in reserve",
        "status": "completed",
        "coding": [
          {
            "system": "http://snomed.info/sct",
            "code": "384682003",
            "display": "Multidisciplinary care conference",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "period": {
          "start": "2026-03-27",
          "end": "2026-03-27"
        },
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007",
            "CLM-0012"
          ],
          "synthetic_reason": "Synthetic tumor board review.",
          "author": "The Human Record generator",
          "created": "2026-11-05T10:00:00-05:00"
        }
      },
      {
        "id": "PROC-008",
        "display": "Chest X-ray, two views: clear lungs, no consolidation, ground-glass change or effusion",
        "status": "completed",
        "coding": [
          {
            "system": "http://snomed.info/sct",
            "code": "399208008",
            "display": "Plain X-ray of chest",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "period": {
          "start": "2026-06-01",
          "end": "2026-06-01"
        },
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007",
            "CLM-0012"
          ],
          "synthetic_reason": "Synthetic chest X-ray to look for pneumonitis in a patient on PD-1 blockade with a new cough.",
          "author": "The Human Record generator",
          "created": "2026-11-05T10:30:00-05:00"
        }
      },
      {
        "id": "PROC-011",
        "display": "Advance care planning conversation, about 20 minutes",
        "status": "completed",
        "coding": [
          {
            "system": "http://snomed.info/sct",
            "code": "713603004",
            "display": "Advance care planning",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "period": {
          "start": "2026-08-10",
          "end": "2026-08-10"
        },
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic voluntary advance care planning; records only her own general preferences.",
          "author": "The Human Record generator",
          "created": "2026-11-05T10:30:00-05:00"
        }
      },
      {
        "id": "PROC-005",
        "display": "Genetic counseling before germline testing: three-generation pedigree as she knows it, consent, and an explanation of what a positive or negative result would mean for her and her blood relatives",
        "status": "completed",
        "coding": [
          {
            "system": "http://snomed.info/sct",
            "code": "79841006",
            "display": "Genetic counseling",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "period": {
          "start": "2026-03-30",
          "end": "2026-03-30"
        },
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007",
            "CLM-0012"
          ],
          "synthetic_reason": "Synthetic genetic counseling for colorectal cancer under 50 with a mismatch repair-deficient tumor.",
          "author": "The Human Record generator",
          "created": "2026-11-05T11:00:00-05:00"
        }
      },
      {
        "id": "PROC-006",
        "display": "Restaging rectal-protocol MRI of the pelvis after four doses: marked regression, with low-signal fibrosis replacing most of the tumor and a small focus of intermediate signal with slight restricted diffusion at the lower margin; mesorectal nodes now 3 mm and smooth; near-complete response",
        "status": "completed",
        "coding": [
          {
            "system": "http://snomed.info/sct",
            "code": "2690005",
            "display": "MRI of pelvis",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "period": {
          "start": "2026-06-24",
          "end": "2026-06-24"
        },
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007",
            "CLM-0012"
          ],
          "synthetic_reason": "Synthetic restaging MRI at about three months.",
          "author": "The Human Record generator",
          "created": "2026-11-05T11:00:00-05:00"
        }
      },
      {
        "id": "PROC-007",
        "display": "Restaging flexible sigmoidoscopy after four doses: a flat white scar where the tumor was, with a 5 mm shallow ulcer at its lower edge; no mass",
        "status": "completed",
        "coding": [
          {
            "system": "http://snomed.info/sct",
            "code": "44441009",
            "display": "Flexible fiberoptic sigmoidoscopy",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "period": {
          "start": "2026-06-25",
          "end": "2026-06-25"
        },
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007",
            "CLM-0012"
          ],
          "synthetic_reason": "Synthetic restaging endoscopy at about three months.",
          "author": "The Human Record generator",
          "created": "2026-11-05T11:00:00-05:00"
        }
      },
      {
        "id": "PROC-009",
        "display": "Final restaging rectal-protocol MRI of the pelvis after nine doses: low-signal fibrosis only, no intermediate signal and no restricted diffusion; no suspicious lymph nodes; complete response on MRI",
        "status": "completed",
        "coding": [
          {
            "system": "http://snomed.info/sct",
            "code": "2690005",
            "display": "MRI of pelvis",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "period": {
          "start": "2026-09-28",
          "end": "2026-09-28"
        },
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007",
            "CLM-0012"
          ],
          "synthetic_reason": "Synthetic final restaging MRI.",
          "author": "The Human Record generator",
          "created": "2026-11-05T11:00:00-05:00"
        }
      },
      {
        "id": "PROC-010",
        "display": "Final restaging CT of the chest, abdomen and pelvis with contrast: no metastases",
        "status": "completed",
        "coding": [
          {
            "system": "http://snomed.info/sct",
            "code": "433761009",
            "display": "CT of thorax, abdomen and pelvis with contrast",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "period": {
          "start": "2026-09-28",
          "end": "2026-09-28"
        },
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007",
            "CLM-0012"
          ],
          "synthetic_reason": "Synthetic final restaging CT.",
          "author": "The Human Record generator",
          "created": "2026-11-05T11:00:00-05:00"
        }
      },
      {
        "id": "PROC-012",
        "display": "Final restaging flexible sigmoidoscopy after nine doses: a flat white scar with fine surface vessels; no ulcer, nodularity or mass; complete endoscopic response",
        "status": "completed",
        "coding": [
          {
            "system": "http://snomed.info/sct",
            "code": "44441009",
            "display": "Flexible fiberoptic sigmoidoscopy",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "period": {
          "start": "2026-09-29",
          "end": "2026-09-29"
        },
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007",
            "CLM-0012"
          ],
          "synthetic_reason": "Synthetic final restaging endoscopy.",
          "author": "The Human Record generator",
          "created": "2026-11-05T11:00:00-05:00"
        }
      }
    ],
    "immunizations": [
      {
        "id": "IMM-001",
        "display": "Tdap vaccine",
        "status": "completed",
        "date": "2021-05-10",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/cvx",
            "code": "115",
            "display": "Tdap",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic adult immunization history in the modern frame; not a historical assertion.",
          "author": "The Human Record generator",
          "created": "2026-11-05T10:00:00-05:00"
        }
      },
      {
        "id": "IMM-002",
        "display": "Hepatitis B vaccine (adjuvanted, two-dose series), dose 1",
        "status": "completed",
        "date": "2026-08-10",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/cvx",
            "code": "189",
            "display": "HepB-CpG",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic hepatitis B vaccination for an adult under 60 with a negative surface antibody before treatment.",
          "author": "The Human Record generator",
          "created": "2026-11-05T10:30:00-05:00"
        }
      },
      {
        "id": "IMM-003",
        "display": "Hepatitis B vaccine (adjuvanted, two-dose series), dose 2, given in the infusion center with the last dose of dostarlimab",
        "status": "completed",
        "date": "2026-09-21",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/cvx",
            "code": "189",
            "display": "HepB-CpG",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic second hepatitis B dose, six weeks after the first.",
          "author": "The Human Record generator",
          "created": "2026-11-05T10:30:00-05:00"
        }
      }
    ],
    "family_history": [],
    "past_medical_history": [],
    "encounters": [
      {
        "id": "ENC-001",
        "display": "Three months of rectal bleeding, narrower stools and urgency, with tiredness, in a professional golfer of 41: examination, blood tests, and colonoscopy this week",
        "status": "finished",
        "date": "2026-03-16",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0006"
          ],
          "synthetic_reason": "Synthetic modern EHR encounter.",
          "author": "The Human Record generator",
          "created": "2026-11-05T10:00:00-05:00"
        }
      },
      {
        "id": "ENC-002",
        "display": "Diagnosis of mismatch repair-deficient low rectal cancer: staging, tumor board plan, medical oncology and colorectal surgery consultation, genetic counseling, and the start of PD-1 blockade",
        "status": "finished",
        "date": "2026-03-30",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007",
            "CLM-0012"
          ],
          "synthetic_reason": "Synthetic modern EHR encounter.",
          "author": "The Human Record generator",
          "created": "2026-11-05T10:00:00-05:00"
        },
        "visit_type": "chronic_care",
        "type_coding": {
          "system": "http://snomed.info/sct",
          "code": "390906007",
          "display": "Follow-up encounter",
          "validation_status": "validated",
          "validated_on": "2026-11-05"
        },
        "documentation": {
          "chief_complaint": "Diagnosis visit: biopsy and staging results, the tumor board plan, and the oncology and surgical consultations",
          "hpi": {
            "narrative": "Ms. Didrikson Zaharias returns two weeks after her first visit. Colonoscopy three days after that visit found an ulcerated mass in the lower rectum, from 4 to 9 cm from the anal verge, and nothing else in the colon; the biopsies show adenocarcinoma, and the tumor has lost the mismatch repair proteins MSH2 and MSH6 and is microsatellite instability high. Rectal-protocol MRI shows a tumor whose lower edge is about 1 cm above the anorectal junction, growing just through the bowel wall, with two suspicious lymph nodes and a clear mesorectal fascia (cT3bN1). CT of the chest, abdomen and pelvis shows no spread. The tumor board met three days ago. She was seen today by Dr. Albright-Nakamura and by the colorectal surgeon, who explained that surgery for a tumor this low would most likely mean removing the rectum and anus with a permanent colostomy. She still passes some bright red blood most days, less than before, and feels tired on the back nine. Her first question was whether she would need a bag; her second was whether she could keep playing.",
            "elements": [
              {
                "label": "Diagnosis",
                "value": "Low rectal adenocarcinoma, mismatch repair deficient (loss of MSH2 and MSH6), cT3bN1M0, stage IIIB"
              },
              {
                "label": "Procedures since the first visit",
                "value": "Colonoscopy with biopsy; rectal-protocol MRI of the pelvis; CT of the chest, abdomen and pelvis; tumor board"
              },
              {
                "label": "Tumor board",
                "value": "Dostarlimab every three weeks for six months, restaging about every three months, and watch-and-wait if the response is complete; chemoradiation and surgery in reserve"
              },
              {
                "label": "Symptoms",
                "value": "Less bleeding; still some urgency; tired late in a round"
              },
              {
                "label": "Her questions",
                "value": "Whether she will need a bag; whether she can keep competing; what the genetic test means for her brothers and sisters"
              }
            ]
          },
          "ros": [
            {
              "system": "Constitutional",
              "status": "positive",
              "finding": "Tired late in a round; weight 62.6 kg, steady; no fever"
            },
            {
              "system": "Gastrointestinal",
              "status": "positive",
              "finding": "Bright red blood on most days, less than before; urgency; narrow stools"
            },
            {
              "system": "Genitourinary",
              "status": "positive",
              "finding": "Pain during sex and spotting afterwards; no urinary symptoms"
            },
            {
              "system": "Cardiovascular",
              "status": "negative",
              "finding": "No palpitations, fainting or leg swelling"
            },
            {
              "system": "Musculoskeletal",
              "status": "negative",
              "finding": "No back or pelvic pain"
            },
            {
              "system": "Psychiatric",
              "status": "positive",
              "finding": "Frightened by the word cancer and determined; PHQ-9 6, GAD-7 7; no thoughts of self-harm"
            }
          ],
          "exam": [
            {
              "system": "General",
              "finding": "Fit, tanned, composed; weight 62.6 kg; blood pressure 116/72, pulse 80"
            },
            {
              "system": "Abdomen",
              "finding": "Soft, non-tender; no liver enlargement or mass"
            },
            {
              "system": "Lymph nodes",
              "finding": "No inguinal or supraclavicular nodes"
            },
            {
              "system": "Rectal",
              "finding": "With her agreement and a chaperone: firm, ulcerated, partly mobile mass on the posterior and left wall, lower edge about 4 to 5 cm from the anal verge; sphincter tone normal; blood on the glove"
            },
            {
              "system": "Psychiatric",
              "finding": "Direct and focused; asks exact questions about her game and about a colostomy"
            }
          ],
          "assessment_plan": [
            {
              "problem_id": "PRB-003",
              "display": "Low rectal adenocarcinoma, mismatch repair deficient, cT3bN1M0",
              "assessment": "Rectal cancer diagnosed two weeks after she first came, because the bleeding in a woman of 41 was examined and scoped at once rather than treated as hemorrhoids. It is locally advanced and low, so standard treatment would be chemoradiation and chemotherapy followed, in most cases, by an abdominoperineal resection and a permanent colostomy. Because the tumor is mismatch repair deficient, the tumor board and Dr. Albright-Nakamura recommend PD-1 blockade with dostarlimab for six months instead, which in the published trials has given a clinical complete response in nearly every patient with this kind of tumor and allowed the rectum to be kept, without radiation or surgery. She agreed, with the understanding that chemoradiation and surgery remain available if the response is not complete",
              "plan": [
                "Dostarlimab 500 mg every three weeks from next week, nine doses",
                "Hepatitis B, hepatitis C and HIV tests drawn today; urine pregnancy test negative today",
                "Germline multigene panel sent after counseling today",
                "Restaging MRI, sigmoidoscopy and rectal examination after four doses"
              ]
            },
            {
              "problem_id": "PRB-002",
              "display": "Iron deficiency anemia from rectal blood loss",
              "assessment": "Hemoglobin 11.1 g/dL today (11.0 at the first visit, with ferritin 9 ng/mL); oral iron was started once the results had been reviewed; bleeding continues but is lessening",
              "plan": [
                "Ferrous sulfate 325 mg every other morning",
                "Blood count in four weeks; ferritin at three months"
              ]
            },
            {
              "problem_id": "PRB-001",
              "display": "Rectal bleeding with a change in bowel habit and a rectal mass",
              "assessment": "Explained by the diagnosis made today; superseded",
              "plan": [
                "Problem resolved"
              ]
            }
          ],
          "monitoring": [
            {
              "domain": "laboratory",
              "measure": "Tissue diagnosis and mismatch repair testing",
              "cadence": "Before treatment; mismatch repair testing for every colorectal cancer",
              "status": "up_to_date",
              "detail": "Adenocarcinoma, moderately differentiated; loss of MSH2 and MSH6 on immunohistochemistry; microsatellite instability high",
              "guideline_ids": [
                "GL-NCCN-RECT-2026",
                "GL-ASCO-LARC-2024"
              ]
            },
            {
              "domain": "imaging",
              "measure": "Rectal-protocol MRI of the pelvis",
              "cadence": "At diagnosis, before any treatment",
              "status": "up_to_date",
              "detail": "cT3b, two suspicious mesorectal nodes (cN1), mesorectal fascia clear by 6 mm, no extramural venous invasion, lower edge about 1 cm above the anorectal junction",
              "guideline_ids": [
                "GL-NCCN-RECT-2026",
                "GL-ASCO-LARC-2024"
              ]
            },
            {
              "domain": "imaging",
              "measure": "CT of the chest, abdomen and pelvis",
              "cadence": "At diagnosis",
              "status": "up_to_date",
              "detail": "No metastases",
              "guideline_ids": [
                "GL-NCCN-RECT-2026",
                "GL-ASCO-LARC-2024"
              ]
            },
            {
              "domain": "referral",
              "measure": "Multidisciplinary tumor board",
              "cadence": "Before treatment for every rectal cancer",
              "status": "up_to_date",
              "detail": "Three days ago: dostarlimab, restaging, watch-and-wait if complete response",
              "guideline_ids": [
                "GL-NCCN-RECT-2026",
                "GL-ASCO-LARC-2024"
              ]
            },
            {
              "domain": "referral",
              "measure": "Colorectal surgery consultation",
              "cadence": "Before treatment of every rectal cancer",
              "status": "completed_today",
              "detail": "Seen today: surgery now would most likely be abdominoperineal resection with a permanent colostomy; surgery kept in reserve for an incomplete response or regrowth",
              "guideline_ids": [
                "GL-NCCN-RECT-2026",
                "GL-ASCO-LARC-2024"
              ]
            },
            {
              "domain": "referral",
              "measure": "Wound-ostomy nursing: stoma site marking and teaching",
              "cadence": "Before any operation that may create a stoma",
              "status": "not_indicated",
              "detail": "No operation planned; to be arranged at once if surgery becomes necessary",
              "guideline_ids": [
                "GL-CMID-2026",
                "GL-NCCN-RECT-2026"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "CEA",
              "cadence": "At diagnosis, at each restaging, then every three to six months for two years",
              "status": "up_to_date",
              "detail": "5.8 ng/mL at the first visit; next with restaging",
              "guideline_ids": [
                "GL-NCCN-RECT-2026"
              ]
            },
            {
              "domain": "examination",
              "measure": "Digital rectal examination",
              "cadence": "At each oncology visit during treatment; every three to four months in watch-and-wait",
              "status": "completed_today",
              "detail": "Lower edge about 4 to 5 cm from the anal verge; sphincter tone normal",
              "guideline_ids": [
                "GL-NCCN-RECT-2026",
                "GL-CERCEK-2022",
                "GL-CERCEK-2025"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Blood count",
              "cadence": "Before each dose of dostarlimab and at each visit; about four weeks after oral iron starts",
              "status": "completed_today",
              "detail": "Hemoglobin 11.1 g/dL, white cells 6.5, platelets 405",
              "observation_ids": [
                "OBS-HGB-V2",
                "OBS-WBC-V2",
                "OBS-PLT-V2"
              ],
              "guideline_ids": [
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Kidney and liver function and glucose",
              "cadence": "At baseline and before each dose of PD-1 blockade",
              "status": "completed_today",
              "detail": "Creatinine 0.76 mg/dL, eGFR 101; ALT 17 U/L, AST 20 U/L; glucose 90 mg/dL",
              "observation_ids": [
                "OBS-CR-V2",
                "OBS-EGFR-V2",
                "OBS-ALT-V2",
                "OBS-AST-V2",
                "OBS-GLU-V2"
              ],
              "guideline_ids": [
                "GL-ASCO-IRAE-2021"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "TSH and free T4",
              "cadence": "At baseline, then every six weeks on PD-1 blockade; six weeks after any levothyroxine change",
              "status": "completed_today",
              "detail": "Baseline TSH 1.9 mIU/L, free T4 1.2 ng/dL",
              "observation_ids": [
                "OBS-TSH-V2",
                "OBS-FT4-V2"
              ],
              "guideline_ids": [
                "GL-ASCO-IRAE-2021"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Hepatitis B, hepatitis C and HIV screening",
              "cadence": "Before systemic cancer treatment",
              "status": "ordered",
              "detail": "Hepatitis B surface antigen, core antibody and surface antibody, hepatitis C antibody and HIV drawn today",
              "guideline_ids": [
                "GL-ASCO-HBV-2020"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Pregnancy test",
              "cadence": "Before treatment",
              "status": "completed_today",
              "detail": "Urine pregnancy test negative",
              "guideline_ids": [
                "GL-ASCO-FERT-2018"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Contraception during PD-1 blockade",
              "cadence": "Throughout treatment and for four months after the last dose",
              "status": "up_to_date",
              "detail": "Levonorgestrel intrauterine device in place",
              "guideline_ids": [
                "GL-ASCO-FERT-2018"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Germline multigene panel",
              "cadence": "For every colorectal cancer diagnosed under 50 and every mismatch repair-deficient tumor",
              "status": "ordered",
              "detail": "Sent today after counseling",
              "guideline_ids": [
                "GL-ASCO-GERM-2024",
                "GL-NCCN-RECT-2026"
              ]
            },
            {
              "domain": "referral",
              "measure": "Genetic counseling",
              "cadence": "Before germline testing",
              "status": "completed_today",
              "detail": "Pedigree as she knows it; she knows of no relative with a Lynch-associated cancer; consent for testing",
              "guideline_ids": [
                "GL-ASCO-GERM-2024",
                "GL-NCCN-RECT-2026"
              ]
            },
            {
              "domain": "self_management",
              "measure": "Teaching about immune-related adverse events",
              "cadence": "Before the first dose",
              "status": "completed_today",
              "detail": "Written guide and 24-hour line: report diarrhea, blood in the stool, rash, cough, breathlessness, unusual tiredness, headache or thirst",
              "guideline_ids": [
                "GL-ASCO-IRAE-2021"
              ]
            },
            {
              "domain": "survey",
              "measure": "Distress and depression screen (PHQ-9, GAD-7)",
              "cadence": "At diagnosis, at each treatment phase, and at least yearly",
              "status": "completed_today",
              "detail": "PHQ-9 6 (item 9 scored 0), GAD-7 7",
              "observation_ids": [
                "OBS-PHQ9-V2",
                "OBS-GAD7-V2"
              ],
              "guideline_ids": [
                "GL-USPSTF-DEP-2023",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "self_management",
              "measure": "Sexual health and body image",
              "cadence": "At diagnosis and through treatment",
              "status": "completed_today",
              "detail": "Pain and spotting after sex explained by the tumor; told they should settle as it responds; a lubricant meanwhile",
              "guideline_ids": [
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "self_management",
              "measure": "Physical activity and sport",
              "cadence": "Each visit",
              "status": "completed_today",
              "detail": "Encouraged to keep playing and training as she feels able; no restriction from dostarlimab",
              "guideline_ids": [
                "GL-ASCO-EX-2022"
              ]
            }
          ],
          "follow_up": "Dostarlimab cycle 1 next week. Primary care review at cycle 2. Call at once for heavy bleeding, fainting, diarrhea, rash, cough or breathlessness",
          "guideline_ids": [
            "GL-NCCN-RECT-2026",
            "GL-ASCO-LARC-2024",
            "GL-CERCEK-2022",
            "GL-CERCEK-2025",
            "GL-ASCO-IRAE-2021",
            "GL-ASCO-GERM-2024",
            "GL-CMID-2026"
          ]
        }
      },
      {
        "id": "ENC-003",
        "display": "Day 1 of cycle 2 of dostarlimab: early response, immune-related adverse event checks, germline and tumor genetic results, iron and anemia, and golf",
        "status": "finished",
        "date": "2026-04-27",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007",
            "CLM-0012"
          ],
          "synthetic_reason": "Synthetic modern EHR encounter.",
          "author": "The Human Record generator",
          "created": "2026-11-05T10:00:00-05:00"
        },
        "visit_type": "chronic_care",
        "type_coding": {
          "system": "http://snomed.info/sct",
          "code": "390906007",
          "display": "Follow-up encounter",
          "validation_status": "validated",
          "validated_on": "2026-11-05"
        },
        "documentation": {
          "chief_complaint": "Day 1 of cycle 2 of dostarlimab",
          "hpi": {
            "narrative": "Ms. Didrikson Zaharias comes before her second dose of dostarlimab. The first dose three weeks ago caused no reaction. Within ten days the bleeding became occasional streaks, and for the last week there has been none; her stools are a normal shape and the urgency has eased. She has had no diarrhea, rash, cough, breathlessness, headache or thirst. She has taken ferrous sulfate every other morning for four weeks, with mild constipation that settled with more fruit, and she is less tired. She is practicing every day and played 18 holes twice last week. The germline panel was negative, and tumor sequencing found two changes in MSH2 in the tumor itself, which explains the mismatch repair deficiency. She asked what this means for her brothers and sisters.",
            "elements": [
              {
                "label": "Treatment",
                "value": "Dostarlimab cycle 1 three weeks ago; cycle 2 today"
              },
              {
                "label": "Symptoms",
                "value": "No bleeding for a week; normal stools; less tired"
              },
              {
                "label": "Adverse events",
                "value": "None"
              },
              {
                "label": "Genetic results",
                "value": "Germline panel negative; two somatic MSH2 variants in the tumor"
              }
            ]
          },
          "ros": [
            {
              "system": "Constitutional",
              "status": "negative",
              "finding": "Energy better; no fever; weight 63.2 kg"
            },
            {
              "system": "Gastrointestinal",
              "status": "negative",
              "finding": "No bleeding for a week; no diarrhea or abdominal pain; mild constipation from iron, settled"
            },
            {
              "system": "Integumentary",
              "status": "negative",
              "finding": "No rash or itching"
            },
            {
              "system": "Respiratory",
              "status": "negative",
              "finding": "No cough or breathlessness"
            },
            {
              "system": "Endocrine",
              "status": "negative",
              "finding": "No heat or cold intolerance, thirst or headache"
            },
            {
              "system": "Psychiatric",
              "status": "negative",
              "finding": "Hopeful; PHQ-9 4; no thoughts of self-harm"
            }
          ],
          "exam": [
            {
              "system": "General",
              "finding": "Well; weight 63.2 kg; blood pressure 110/68, pulse 70"
            },
            {
              "system": "Skin",
              "finding": "No rash"
            },
            {
              "system": "Neck",
              "finding": "Thyroid not enlarged or tender"
            },
            {
              "system": "Abdomen",
              "finding": "Soft, non-tender"
            },
            {
              "system": "Rectal",
              "finding": "With her agreement and a chaperone: the mass is smaller and softer, with a flatter edge; no blood on the glove"
            }
          ],
          "assessment_plan": [
            {
              "problem_id": "PRB-003",
              "display": "Low rectal adenocarcinoma, mismatch repair deficient, on dostarlimab",
              "assessment": "An early clinical response after one dose: the bleeding has stopped, the tumor is smaller to the finger, and CEA has fallen from 5.8 to 3.4 ng/mL. No immune-related adverse event; thyroid, liver and kidney tests normal. The germline panel found no pathogenic variant in MLH1, MSH2, MSH6, PMS2, EPCAM or the other colorectal cancer genes, and tumor sequencing found two somatic MSH2 variants, so this is a sporadic mismatch repair-deficient cancer rather than Lynch syndrome. Her first-degree relatives still have a raised risk because she had colorectal cancer young, and are advised to start colonoscopy at 40, or 10 years before her age at diagnosis if that is earlier, and repeat it every five years. Hepatitis B, hepatitis C and HIV tests were negative; hepatitis B surface antibody was negative, so vaccination is due",
              "plan": [
                "Dostarlimab cycle 2 today",
                "A letter for her to share with her brothers and sisters, if she chooses, explaining their screening",
                "Restaging MRI, sigmoidoscopy and examination after four doses"
              ]
            },
            {
              "problem_id": "PRB-002",
              "display": "Iron deficiency anemia from rectal blood loss",
              "assessment": "Hemoglobin up from 11.1 to 12.1 g/dL and MCV from 77 to 80 fL four weeks after starting oral iron, with the bleeding stopped",
              "plan": [
                "Continue ferrous sulfate every other morning",
                "Ferritin at about three months"
              ]
            }
          ],
          "monitoring": [
            {
              "domain": "laboratory",
              "measure": "Blood count",
              "cadence": "Before each dose of dostarlimab and at each visit; about four weeks after oral iron starts",
              "status": "completed_today",
              "detail": "Four weeks after oral iron: hemoglobin 12.1 g/dL, MCV 80 fL, white cells 6.2, platelets 352",
              "observation_ids": [
                "OBS-HGB-V3",
                "OBS-MCV-V3",
                "OBS-WBC-V3",
                "OBS-PLT-V3"
              ],
              "guideline_ids": [
                "GL-CMID-2026",
                "GL-ASCO-IRAE-2021"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Kidney and liver function and glucose",
              "cadence": "Before each dose of PD-1 blockade",
              "status": "completed_today",
              "detail": "Creatinine 0.74 mg/dL, eGFR 104; ALT 22 U/L, AST 24 U/L; glucose 92 mg/dL",
              "observation_ids": [
                "OBS-CR-V3",
                "OBS-EGFR-V3",
                "OBS-ALT-V3",
                "OBS-AST-V3",
                "OBS-GLU-V3"
              ],
              "guideline_ids": [
                "GL-ASCO-IRAE-2021"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "TSH and free T4",
              "cadence": "At baseline, then every six weeks on PD-1 blockade; six weeks after any levothyroxine change",
              "status": "completed_today",
              "detail": "TSH 2.2 mIU/L, free T4 1.2 ng/dL",
              "observation_ids": [
                "OBS-TSH-V3",
                "OBS-FT4-V3"
              ],
              "guideline_ids": [
                "GL-ASCO-IRAE-2021"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "CEA",
              "cadence": "During treatment, as a marker of response",
              "status": "completed_today",
              "detail": "3.4 ng/mL, down from 5.8",
              "observation_ids": [
                "OBS-CEA-V3"
              ],
              "guideline_ids": [
                "GL-NCCN-RECT-2026"
              ]
            },
            {
              "domain": "examination",
              "measure": "Digital rectal examination",
              "cadence": "At each oncology visit during treatment; every three to four months in watch-and-wait",
              "status": "completed_today",
              "detail": "Mass smaller and softer; no blood",
              "guideline_ids": [
                "GL-NCCN-RECT-2026",
                "GL-CERCEK-2022",
                "GL-CERCEK-2025"
              ]
            },
            {
              "domain": "examination",
              "measure": "Immune-related adverse event review (diarrhea, rash, cough, breathlessness, fatigue, endocrine symptoms)",
              "cadence": "Before each dose",
              "status": "completed_today",
              "detail": "None",
              "guideline_ids": [
                "GL-ASCO-IRAE-2021"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Germline multigene panel and tumor sequencing",
              "cadence": "Germline result before treatment decisions that depend on it; tumor sequencing when the germline panel is negative",
              "status": "completed_today",
              "detail": "Germline negative; two somatic MSH2 variants in the tumor; KRAS, NRAS and BRAF wild type",
              "guideline_ids": [
                "GL-ASCO-GERM-2024",
                "GL-NCCN-RECT-2026"
              ]
            },
            {
              "domain": "self_management",
              "measure": "Screening advice for first-degree relatives",
              "cadence": "Once the genetic results are known",
              "status": "completed_today",
              "detail": "Colonoscopy from 40, or 10 years before her age at diagnosis if earlier, every five years; letter given for her to share as she chooses",
              "guideline_ids": [
                "GL-USMSTF-2017",
                "GL-ASCO-GERM-2024"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Hepatitis B, hepatitis C and HIV screening",
              "cadence": "Before systemic cancer treatment",
              "status": "up_to_date",
              "detail": "All negative; hepatitis B surface antibody negative, so vaccination is due",
              "guideline_ids": [
                "GL-ASCO-HBV-2020"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Ferritin after oral iron",
              "cadence": "About three months after starting",
              "status": "due",
              "detail": "Due at the restaging visit",
              "guideline_ids": [
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "imaging",
              "measure": "Restaging pelvic MRI and flexible sigmoidoscopy",
              "cadence": "About every three months during treatment",
              "status": "due",
              "detail": "Booked for the week before cycle 5",
              "guideline_ids": [
                "GL-NCCN-RECT-2026",
                "GL-CERCEK-2022",
                "GL-CERCEK-2025"
              ]
            },
            {
              "domain": "survey",
              "measure": "Distress and depression screen (PHQ-9, GAD-7)",
              "cadence": "At diagnosis, at each treatment phase, and at least yearly",
              "status": "completed_today",
              "detail": "PHQ-9 4; item 9 scored 0",
              "observation_ids": [
                "OBS-PHQ9-V3"
              ],
              "guideline_ids": [
                "GL-USPSTF-DEP-2023",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "self_management",
              "measure": "Physical activity and sport",
              "cadence": "Each visit",
              "status": "completed_today",
              "detail": "Playing 18 holes and practicing daily",
              "guideline_ids": [
                "GL-ASCO-EX-2022"
              ]
            }
          ],
          "follow_up": "Cycles 3 and 4 as booked; restaging MRI and sigmoidoscopy in about eight weeks; primary care review at cycle 5",
          "guideline_ids": [
            "GL-NCCN-RECT-2026",
            "GL-CERCEK-2022",
            "GL-ASCO-IRAE-2021",
            "GL-ASCO-GERM-2024",
            "GL-USMSTF-2017",
            "GL-CMID-2026"
          ]
        }
      },
      {
        "id": "ENC-004",
        "display": "Restaging after four doses: pelvic MRI and endoscopy, immune-related hypothyroidism, and the decision to continue PD-1 blockade",
        "status": "finished",
        "date": "2026-06-29",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007",
            "CLM-0012"
          ],
          "synthetic_reason": "Synthetic modern EHR encounter.",
          "author": "The Human Record generator",
          "created": "2026-11-05T10:00:00-05:00"
        },
        "visit_type": "chronic_care",
        "type_coding": {
          "system": "http://snomed.info/sct",
          "code": "390906007",
          "display": "Follow-up encounter",
          "validation_status": "validated",
          "validated_on": "2026-11-05"
        },
        "documentation": {
          "chief_complaint": "Restaging after four doses of dostarlimab, and tiredness with cold hands",
          "hpi": {
            "narrative": "Ms. Didrikson Zaharias comes on the day of her fifth dose, after restaging MRI and sigmoidoscopy last week. The cold she had in early June cleared within a week and she had cycle 4 on time. Over the last month she has become tired again, with cold hands on the course, dry skin and slightly heavier legs; her weight is up 0.8 kg. At the sick visit four weeks ago the TSH was 5.8 mIU/L with a normal free T4. Her bowel movements are normal, with no bleeding, and she has had no diarrhea, rash, cough or breathlessness. Sex is comfortable again. She is playing 18 holes and has entered a club competition next month.",
            "elements": [
              {
                "label": "Treatment",
                "value": "Dostarlimab cycles 1 to 4 on schedule; cycle 5 today"
              },
              {
                "label": "Restaging",
                "value": "MRI: near-complete response; sigmoidoscopy: flat scar with a 5 mm shallow ulcer"
              },
              {
                "label": "New symptoms",
                "value": "Tiredness, cold hands, dry skin for a month"
              },
              {
                "label": "Sport",
                "value": "Playing 18 holes; entered a club competition"
              }
            ]
          },
          "ros": [
            {
              "system": "Constitutional",
              "status": "positive",
              "finding": "Tired for a month; weight 63.8 kg, up 0.8 kg"
            },
            {
              "system": "Integumentary",
              "status": "positive",
              "finding": "Dry skin; no rash"
            },
            {
              "system": "Endocrine",
              "status": "positive",
              "finding": "Cold hands; no thirst or headache"
            },
            {
              "system": "Gastrointestinal",
              "status": "negative",
              "finding": "Normal bowel movements; no bleeding or diarrhea; mild constipation"
            },
            {
              "system": "Respiratory",
              "status": "negative",
              "finding": "Cough gone; no breathlessness"
            },
            {
              "system": "Psychiatric",
              "status": "negative",
              "finding": "Pleased with the scans; PHQ-9 3; no thoughts of self-harm"
            }
          ],
          "exam": [
            {
              "system": "General",
              "finding": "Well; weight 63.8 kg; blood pressure 114/72, pulse 60; temperature 36.4 °C"
            },
            {
              "system": "Neck",
              "finding": "Thyroid not enlarged or tender"
            },
            {
              "system": "Skin",
              "finding": "Dry skin on the shins; no rash"
            },
            {
              "system": "Neurological",
              "finding": "Ankle reflexes with slightly slow relaxation"
            },
            {
              "system": "Rectal",
              "finding": "With her agreement and a chaperone: smooth, with a small firm irregularity at about 4 cm; no mass; no blood"
            }
          ],
          "assessment_plan": [
            {
              "problem_id": "PRB-003",
              "display": "Low rectal adenocarcinoma, mismatch repair deficient, on dostarlimab",
              "assessment": "Near-complete response after four doses: MRI shows fibrosis replacing most of the tumor with a small focus of possible residual tumor at the lower margin and normal-sized nodes; sigmoidoscopy shows a flat scar with a small shallow ulcer; CEA 2.1 ng/mL, now normal. Biopsy of the scar was not taken, since a negative result would not change the plan. Treatment continues to nine doses, as planned, with final restaging after the last dose",
              "plan": [
                "Dostarlimab cycle 5 today; cycles 6 to 9 as booked",
                "Final restaging MRI, CT, sigmoidoscopy and examination after cycle 9"
              ]
            },
            {
              "problem_id": "PRB-004",
              "display": "Immune-related primary hypothyroidism, grade 2",
              "assessment": "TSH 12.6 mIU/L with free T4 0.6 ng/dL, after a mild rise to 5.8 four weeks ago, with tiredness, cold hands, dry skin and a pulse of 60: primary hypothyroidism from immune thyroiditis caused by dostarlimab. The TSH is high, so this is thyroid failure, not pituitary inflammation, and a cortisol test is not needed. Under the ASCO guideline, immunotherapy continues and thyroid hormone is replaced; this kind of hypothyroidism is usually permanent",
              "plan": [
                "Levothyroxine 75 micrograms each morning, four hours apart from iron",
                "TSH and free T4 in six weeks",
                "Dostarlimab continues"
              ]
            },
            {
              "problem_id": "PRB-002",
              "display": "Iron deficiency anemia from rectal blood loss",
              "assessment": "Hemoglobin 13.0 g/dL, now normal, with no bleeding for two months. The ferritin due at three months was not drawn",
              "plan": [
                "Continue ferrous sulfate for three months after the hemoglobin became normal",
                "Ferritin with the final restaging blood tests"
              ]
            },
            {
              "problem_id": "PRB-005",
              "display": "Acute viral upper respiratory infection",
              "assessment": "Resolved within a week; no pneumonitis",
              "plan": [
                "Problem resolved"
              ]
            }
          ],
          "monitoring": [
            {
              "domain": "imaging",
              "measure": "Restaging pelvic MRI and flexible sigmoidoscopy",
              "cadence": "About every three months during treatment",
              "status": "up_to_date",
              "detail": "Last week: near-complete response on MRI; flat scar with a 5 mm shallow ulcer on sigmoidoscopy",
              "guideline_ids": [
                "GL-NCCN-RECT-2026",
                "GL-CERCEK-2022",
                "GL-CERCEK-2025"
              ]
            },
            {
              "domain": "examination",
              "measure": "Digital rectal examination",
              "cadence": "At each oncology visit during treatment; every three to four months in watch-and-wait",
              "status": "completed_today",
              "detail": "Smooth, with a small firm irregularity at about 4 cm; no mass",
              "guideline_ids": [
                "GL-NCCN-RECT-2026",
                "GL-CERCEK-2022",
                "GL-CERCEK-2025"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "CEA",
              "cadence": "At diagnosis, at each restaging, then every three to six months for two years",
              "status": "completed_today",
              "detail": "2.1 ng/mL, normal",
              "observation_ids": [
                "OBS-CEA-V4"
              ],
              "guideline_ids": [
                "GL-NCCN-RECT-2026"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Blood count",
              "cadence": "Before each dose of dostarlimab and at each visit; about four weeks after oral iron starts",
              "status": "completed_today",
              "detail": "Hemoglobin 13.0 g/dL, white cells 6.0, platelets 268",
              "observation_ids": [
                "OBS-HGB-V4",
                "OBS-WBC-V4",
                "OBS-PLT-V4"
              ],
              "guideline_ids": [
                "GL-CMID-2026",
                "GL-ASCO-IRAE-2021"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Kidney and liver function and glucose",
              "cadence": "Before each dose of PD-1 blockade",
              "status": "completed_today",
              "detail": "Sodium 140, potassium 4.2 mmol/L; creatinine 0.75 mg/dL, eGFR 102; glucose 89 mg/dL; ALT 20, AST 22, alkaline phosphatase 70 U/L; bilirubin 0.5 mg/dL; albumin 4.4 g/dL",
              "observation_ids": [
                "OBS-NA-V4",
                "OBS-K-V4",
                "OBS-CR-V4",
                "OBS-EGFR-V4",
                "OBS-GLU-V4",
                "OBS-ALT-V4",
                "OBS-AST-V4",
                "OBS-ALP-V4",
                "OBS-TBIL-V4",
                "OBS-ALB-V4"
              ],
              "guideline_ids": [
                "GL-ASCO-IRAE-2021"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "TSH and free T4",
              "cadence": "At baseline, then every six weeks on PD-1 blockade; six weeks after any levothyroxine change",
              "status": "completed_today",
              "detail": "TSH 12.6 mIU/L, free T4 0.6 ng/dL: hypothyroidism; levothyroxine started; TSH checks four and five weeks apart since the last visit",
              "observation_ids": [
                "OBS-TSH-V4",
                "OBS-FT4-V4"
              ],
              "guideline_ids": [
                "GL-ASCO-IRAE-2021",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "examination",
              "measure": "Immune-related adverse event review (diarrhea, rash, cough, breathlessness, fatigue, endocrine symptoms)",
              "cadence": "Before each dose",
              "status": "completed_today",
              "detail": "Hypothyroidism, grade 2; no colitis, rash, pneumonitis or hepatitis",
              "guideline_ids": [
                "GL-ASCO-IRAE-2021"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Ferritin after oral iron",
              "cadence": "About three months after starting",
              "status": "deferred",
              "detail": "Missed: the ferritin due about three months after oral iron began was not added to the restaging blood tests. No harm is expected, because the bleeding has stopped and the hemoglobin is normal; corrective action: ferritin added to the final restaging blood tests, and iron continued until then",
              "guideline_ids": [
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "survey",
              "measure": "Distress and depression screen (PHQ-9, GAD-7)",
              "cadence": "At diagnosis, at each treatment phase, and at least yearly",
              "status": "completed_today",
              "detail": "PHQ-9 3; item 9 scored 0",
              "observation_ids": [
                "OBS-PHQ9-V4"
              ],
              "guideline_ids": [
                "GL-USPSTF-DEP-2023",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "self_management",
              "measure": "Sexual health and body image",
              "cadence": "Through treatment",
              "status": "completed_today",
              "detail": "Sex comfortable again since the bleeding stopped",
              "guideline_ids": [
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "self_management",
              "measure": "Physical activity and sport",
              "cadence": "Each visit",
              "status": "completed_today",
              "detail": "Playing 18 holes; entered a club competition",
              "guideline_ids": [
                "GL-ASCO-EX-2022"
              ]
            }
          ],
          "follow_up": "Dostarlimab cycles 6 to 9 as booked; TSH and free T4 in six weeks; final restaging after cycle 9; preventive visit due",
          "guideline_ids": [
            "GL-NCCN-RECT-2026",
            "GL-CERCEK-2022",
            "GL-CERCEK-2025",
            "GL-ASCO-IRAE-2021",
            "GL-CMID-2026"
          ]
        }
      },
      {
        "id": "ENC-005",
        "display": "After nine doses: final restaging, clinical complete response, and the watch-and-wait surveillance plan",
        "status": "finished",
        "date": "2026-10-05",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007",
            "CLM-0012"
          ],
          "synthetic_reason": "Synthetic modern EHR encounter.",
          "author": "The Human Record generator",
          "created": "2026-11-05T10:00:00-05:00"
        },
        "visit_type": "chronic_care",
        "type_coding": {
          "system": "http://snomed.info/sct",
          "code": "390906007",
          "display": "Follow-up encounter",
          "validation_status": "validated",
          "validated_on": "2026-11-05"
        },
        "documentation": {
          "chief_complaint": "Final restaging after nine doses of dostarlimab",
          "hpi": {
            "narrative": "Ms. Didrikson Zaharias returns two weeks after her ninth and last dose of dostarlimab. Final restaging last week showed only fibrosis on MRI, no metastases on CT, and a flat white scar with no ulcer on sigmoidoscopy. She has had no bleeding, urgency or change in bowel habit for five months, and no diarrhea, rash, cough or breathlessness. She takes levothyroxine 75 micrograms each morning, has no tiredness or cold intolerance, and is still taking ferrous sulfate. The second hepatitis B vaccine dose was given with the last dose of dostarlimab. She played four tournaments over the summer and won a regional event last month. She asked what watch-and-wait means and how she will know if the cancer comes back.",
            "elements": [
              {
                "label": "Treatment",
                "value": "Nine doses of dostarlimab over six months, completed two weeks ago"
              },
              {
                "label": "Restaging",
                "value": "MRI: complete response; CT: no metastases; sigmoidoscopy: flat white scar, no ulcer"
              },
              {
                "label": "Adverse events",
                "value": "Immune-related hypothyroidism, replaced; nothing else"
              },
              {
                "label": "Sport",
                "value": "Competing; won a regional event last month"
              }
            ]
          },
          "ros": [
            {
              "system": "Constitutional",
              "status": "negative",
              "finding": "Energy good; weight 63.4 kg, steady"
            },
            {
              "system": "Gastrointestinal",
              "status": "negative",
              "finding": "Normal bowel movements; no bleeding, urgency or leakage"
            },
            {
              "system": "Endocrine",
              "status": "negative",
              "finding": "No cold intolerance or palpitations"
            },
            {
              "system": "Genitourinary",
              "status": "negative",
              "finding": "Sex comfortable; no urinary symptoms"
            },
            {
              "system": "Respiratory",
              "status": "negative",
              "finding": "No cough or breathlessness"
            },
            {
              "system": "Psychiatric",
              "status": "negative",
              "finding": "Relieved; some worry before each scan; PHQ-9 2, GAD-7 3; no thoughts of self-harm"
            }
          ],
          "exam": [
            {
              "system": "General",
              "finding": "Fit and well; weight 63.4 kg; blood pressure 112/70, pulse 64"
            },
            {
              "system": "Neck",
              "finding": "Thyroid not enlarged"
            },
            {
              "system": "Lymph nodes",
              "finding": "No inguinal or supraclavicular nodes"
            },
            {
              "system": "Abdomen",
              "finding": "Soft, non-tender; no liver enlargement or mass"
            },
            {
              "system": "Rectal",
              "finding": "With her agreement and a chaperone: smooth, supple wall; no mass, nodule or ulcer; normal sphincter tone; no blood"
            }
          ],
          "assessment_plan": [
            {
              "problem_id": "PRB-003",
              "display": "Low rectal adenocarcinoma, mismatch repair deficient, after dostarlimab: clinical complete response",
              "assessment": "Clinical complete response on all three tests that define it: a normal rectal examination, a flat white scar without ulcer or nodularity on endoscopy, and only fibrosis without restricted diffusion on MRI; CT shows no metastases and CEA is 1.6 ng/mL. With the tumor board, she chose watch-and-wait: no radiation and no surgery, with close surveillance so that any regrowth can be removed early. She keeps her rectum and anus, and will not need a colostomy unless the tumor regrows",
              "plan": [
                "Watch-and-wait: rectal examination and sigmoidoscopy every three to four months and pelvic MRI every six months for two years",
                "CEA every three to six months; CT of the chest, abdomen and pelvis every six to twelve months; colonoscopy at one year",
                "Written survivorship care plan given today",
                "Screening advice for first-degree relatives repeated"
              ]
            },
            {
              "problem_id": "PRB-004",
              "display": "Immune-related primary hypothyroidism on levothyroxine",
              "assessment": "TSH 2.4 mIU/L and free T4 1.2 ng/dL on levothyroxine 75 micrograms; symptoms gone. The TSH due with the ninth dose was not drawn",
              "plan": [
                "Continue levothyroxine 75 micrograms",
                "TSH in six months, then yearly"
              ]
            },
            {
              "problem_id": "PRB-002",
              "display": "Iron deficiency anemia from rectal blood loss",
              "assessment": "Hemoglobin 13.4 g/dL and ferritin 41 ng/mL: anemia corrected and stores partly refilled",
              "plan": [
                "Ferrous sulfate for three more months, then stop",
                "Blood count with the next surveillance visit"
              ]
            }
          ],
          "monitoring": [
            {
              "domain": "imaging",
              "measure": "Final restaging pelvic MRI, CT of the chest, abdomen and pelvis, and flexible sigmoidoscopy",
              "cadence": "After the last dose",
              "status": "up_to_date",
              "detail": "Last week: complete response on MRI and endoscopy; no metastases on CT",
              "guideline_ids": [
                "GL-NCCN-RECT-2026",
                "GL-CERCEK-2022",
                "GL-CERCEK-2025"
              ]
            },
            {
              "domain": "examination",
              "measure": "Digital rectal examination",
              "cadence": "At each oncology visit during treatment; every three to four months in watch-and-wait",
              "status": "completed_today",
              "detail": "Normal; no mass or ulcer",
              "guideline_ids": [
                "GL-NCCN-RECT-2026",
                "GL-CERCEK-2022",
                "GL-CERCEK-2025",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "CEA",
              "cadence": "At diagnosis, at each restaging, then every three to six months for two years",
              "status": "completed_today",
              "detail": "1.6 ng/mL",
              "observation_ids": [
                "OBS-CEA-V5"
              ],
              "guideline_ids": [
                "GL-NCCN-RECT-2026",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Blood count",
              "cadence": "After treatment and with surveillance",
              "status": "completed_today",
              "detail": "Hemoglobin 13.4 g/dL, MCV 86 fL, white cells 6.1, platelets 255",
              "observation_ids": [
                "OBS-HGB-V5",
                "OBS-MCV-V5",
                "OBS-WBC-V5",
                "OBS-PLT-V5"
              ],
              "guideline_ids": [
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Ferritin after oral iron",
              "cadence": "About three months after starting",
              "status": "completed_today",
              "detail": "41 ng/mL, drawn late (deviation recorded at the fourth visit)",
              "observation_ids": [
                "OBS-FERR-V5"
              ],
              "guideline_ids": [
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Kidney and liver function",
              "cadence": "After PD-1 blockade",
              "status": "completed_today",
              "detail": "Creatinine 0.77 mg/dL, eGFR 99; ALT 19, AST 21 U/L",
              "observation_ids": [
                "OBS-CR-V5",
                "OBS-EGFR-V5",
                "OBS-ALT-V5",
                "OBS-AST-V5"
              ],
              "guideline_ids": [
                "GL-ASCO-IRAE-2021"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "TSH and free T4",
              "cadence": "At baseline, then every six weeks on PD-1 blockade; six weeks after any levothyroxine change",
              "status": "completed_today",
              "detail": "TSH 2.4 mIU/L, free T4 1.2 ng/dL on levothyroxine 75 micrograms",
              "observation_ids": [
                "OBS-TSH-V5",
                "OBS-FT4-V5"
              ],
              "guideline_ids": [
                "GL-ASCO-IRAE-2021",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "TSH and free T4 with the ninth dose",
              "cadence": "Every six weeks on PD-1 blockade",
              "status": "deferred",
              "detail": "Missed: the thyroid tests due with the ninth dose, six weeks after the preventive visit, were not on the infusion order. No harm resulted, since the TSH today, eight weeks after the last check, is in range on an unchanged dose; corrective action: thyroid tests added to her standing surveillance order set, and the infusion center's PD-1 order set reviewed so that thyroid tests repeat automatically every six weeks",
              "guideline_ids": [
                "GL-ASCO-IRAE-2021",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "imaging",
              "measure": "Pelvic MRI in watch-and-wait",
              "cadence": "Every six months for two to three years",
              "status": "due",
              "detail": "Next in six months",
              "guideline_ids": [
                "GL-NCCN-RECT-2026",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "imaging",
              "measure": "Flexible sigmoidoscopy in watch-and-wait",
              "cadence": "Every three to four months for two years, then every six months to five years",
              "status": "due",
              "detail": "Next in three months",
              "guideline_ids": [
                "GL-NCCN-RECT-2026",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "imaging",
              "measure": "CT of the chest, abdomen and pelvis",
              "cadence": "Every six to twelve months for five years",
              "status": "due",
              "detail": "Next in six to twelve months",
              "guideline_ids": [
                "GL-NCCN-RECT-2026",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "imaging",
              "measure": "Colonoscopy",
              "cadence": "At one year",
              "status": "due",
              "detail": "Next in one year",
              "guideline_ids": [
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "self_management",
              "measure": "Survivorship care plan",
              "cadence": "Within a year of completing treatment",
              "status": "completed_today",
              "detail": "Written treatment summary, surveillance schedule and warning signs given to her",
              "guideline_ids": [
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "self_management",
              "measure": "Bowel function (low anterior resection syndrome, incontinence)",
              "cadence": "After rectal surgery or radiation",
              "status": "not_indicated",
              "detail": "No surgery or radiation; bowel function normal",
              "guideline_ids": [
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "referral",
              "measure": "Wound-ostomy nursing",
              "cadence": "If a stoma is created",
              "status": "not_indicated",
              "detail": "No stoma",
              "guideline_ids": [
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "self_management",
              "measure": "Sexual function and fertility",
              "cadence": "Through survivorship",
              "status": "completed_today",
              "detail": "Sex comfortable; contraception continued for four months after the last dose; not planning a pregnancy",
              "guideline_ids": [
                "GL-CMID-2026",
                "GL-ASCO-FERT-2018"
              ]
            },
            {
              "domain": "survey",
              "measure": "Distress and depression screen (PHQ-9, GAD-7)",
              "cadence": "At diagnosis, at each treatment phase, and at least yearly",
              "status": "completed_today",
              "detail": "PHQ-9 2 (item 9 scored 0), GAD-7 3",
              "observation_ids": [
                "OBS-PHQ9-V5",
                "OBS-GAD7-V5"
              ],
              "guideline_ids": [
                "GL-USPSTF-DEP-2023",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "self_management",
              "measure": "Lifestyle: activity, diet and alcohol",
              "cadence": "Each visit",
              "status": "completed_today",
              "detail": "Golf and strength work most days; red meat cut back; alcohol rare",
              "guideline_ids": [
                "GL-ASCO-EX-2022",
                "GL-CMID-2026"
              ]
            }
          ],
          "follow_up": "Sigmoidoscopy and examination in three months; MRI in six months; primary care review in three months with TSH at six months",
          "guideline_ids": [
            "GL-NCCN-RECT-2026",
            "GL-CERCEK-2025",
            "GL-ASCO-IRAE-2021",
            "GL-USMSTF-2017",
            "GL-CMID-2026"
          ]
        }
      },
      {
        "id": "ENC-006",
        "display": "Same-day sick visit for cough and sore throat during immunotherapy",
        "status": "finished",
        "date": "2026-06-01",
        "visit_type": "sick",
        "type_coding": {
          "system": "http://snomed.info/sct",
          "code": "185345009",
          "display": "Encounter for symptom",
          "validation_status": "validated",
          "validated_on": "2026-11-05"
        },
        "documentation": {
          "chief_complaint": "Cough, sore throat and a low fever for three days, on immunotherapy",
          "billing_note": "Problem-oriented office visit, established patient, with a chest X-ray and rapid respiratory tests",
          "hpi": {
            "narrative": "Ms. Didrikson Zaharias called the oncology line three days into a cough and was seen the same day. She had three doses of dostarlimab, the last two weeks ago, and cycle 4 is due in a week. The illness began with a scratchy throat and a runny nose after a tournament week in which several players in the locker room had colds. She now has a dry cough, worse at night, and a temperature up to 37.9 °C at home. She is not short of breath, even climbing the slope to the eighteenth green, and has no chest pain. She has no diarrhea, rash, or abdominal pain, and her bowel movements have been normal since the second dose, with no blood. She has felt more tired than usual for about two weeks, before the cold began. She is practicing but skipped yesterday's round. She has had no thoughts of self-harm.",
            "elements": [
              {
                "label": "Onset",
                "value": "Three days ago, after colds among players at a tournament"
              },
              {
                "label": "Severity",
                "value": "Dry cough, worse at night; temperature up to 37.9 °C; not short of breath"
              },
              {
                "label": "Context",
                "value": "Three doses of dostarlimab; a new cough on PD-1 blockade must prompt a check for pneumonitis"
              },
              {
                "label": "Associated signs and symptoms",
                "value": "Runny nose and sore throat; tired for two weeks; no diarrhea, rash or chest pain"
              }
            ]
          },
          "ros": [
            {
              "system": "Constitutional",
              "status": "positive",
              "finding": "Low fever; tired for about two weeks, before the cold began"
            },
            {
              "system": "Ears, nose, mouth, and throat",
              "status": "positive",
              "finding": "Sore throat and runny nose"
            },
            {
              "system": "Respiratory",
              "status": "positive",
              "finding": "Dry cough; no breathlessness on exertion, wheeze or blood in the sputum"
            },
            {
              "system": "Cardiovascular",
              "status": "negative",
              "finding": "No chest pain, palpitations or leg swelling"
            },
            {
              "system": "Gastrointestinal",
              "status": "negative",
              "finding": "Bowel movements normal; no blood, diarrhea or abdominal pain"
            },
            {
              "system": "Integumentary",
              "status": "negative",
              "finding": "No rash or itching"
            },
            {
              "system": "Endocrine",
              "status": "negative",
              "finding": "No cold intolerance, weight change or thirst"
            },
            {
              "system": "Psychiatric",
              "status": "negative",
              "finding": "Annoyed at missing a round; no thoughts of self-harm"
            }
          ],
          "exam": [
            {
              "system": "General",
              "finding": "Well, talking in full sentences; temperature 37.9 °C; weight 63.0 kg"
            },
            {
              "system": "Vital signs",
              "finding": "Oxygen saturation 98% at rest and 97% after a brisk walk along the corridor; respiratory rate 16"
            },
            {
              "system": "Head, eyes, ears, nose, and throat",
              "finding": "Pharynx red without exudate; nasal congestion; no sinus tenderness; ear drums normal"
            },
            {
              "system": "Neck",
              "finding": "Small tender anterior cervical nodes; thyroid not enlarged or tender"
            },
            {
              "system": "Respiratory",
              "finding": "Clear to auscultation bilaterally; no crackles or wheeze"
            },
            {
              "system": "Skin",
              "finding": "No rash"
            }
          ],
          "assessment_plan": [
            {
              "problem_id": "PRB-005",
              "display": "Acute viral upper respiratory infection",
              "assessment": "A viral cold with cough after exposure on tour. On PD-1 blockade a new cough must raise the question of pneumonitis, but her oxygen saturation is normal at rest and on exertion, the lungs are clear and the chest X-ray is clear, so pneumonitis is unlikely (grade 0). Rapid influenza and COVID-19 tests were negative. No antibiotic is needed",
              "plan": [
                "Fluids, rest, honey and warm drinks for the cough; acetaminophen for fever",
                "Call at once for breathlessness, oxygen saturation below 94% on her home oximeter, chest pain or fever above 38.5 °C; any of these would need a CT of the chest",
                "Cycle 4 next week if the fever has gone"
              ]
            },
            {
              "problem_id": "PRB-003",
              "display": "Mismatch repair-deficient low rectal cancer on dostarlimab",
              "assessment": "Three doses given; bleeding has stopped and bowel habit is normal. The two weeks of tiredness before the cold led to a thyroid check today: TSH 5.8 mIU/L with a normal free T4 of 1.0 ng/dL, a mild rise from 2.2 at the last visit, which can be the start of immune-related thyroiditis. No treatment is needed at this level",
              "plan": [
                "TSH and free T4 again before cycle 5, with the restaging visit",
                "Restaging MRI and sigmoidoscopy as booked"
              ]
            }
          ],
          "follow_up": "Cycle 4 in one week if afebrile. Restaging and review at cycle 5. Call for breathlessness, chest pain, diarrhea, rash or high fever",
          "guideline_ids": [
            "GL-ASCO-IRAE-2021",
            "GL-NCCN-RECT-2026"
          ]
        },
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007",
            "CLM-0012"
          ],
          "synthetic_reason": "Synthetic unscheduled sick visit; the illness is a synthetic intercurrent infection, not a historical claim.",
          "author": "The Human Record generator",
          "created": "2026-11-05T10:30:00-05:00"
        }
      },
      {
        "id": "ENC-007",
        "display": "Periodic adult preventive visit during immunotherapy",
        "status": "finished",
        "date": "2026-08-10",
        "visit_type": "preventive_adult",
        "type_coding": {
          "system": "http://snomed.info/sct",
          "code": "86013001",
          "display": "Periodic reevaluation and management of healthy individual",
          "validation_status": "validated",
          "validated_on": "2026-11-05"
        },
        "documentation": {
          "chief_complaint": "Periodic adult preventive visit, on the day of cycle 7 of dostarlimab",
          "billing_note": "CPT 99396 (periodic preventive medicine, established patient, age 40 to 64) with CPT 99497 (advance care planning) on the same day",
          "health_risk_assessment_method": "Completed by the patient on a tablet in the waiting room and reviewed with her by Dr. Vasquez-Thornbury",
          "hpi": {
            "narrative": "Ms. Didrikson Zaharias, now 42, comes for her yearly preventive visit on the morning of her seventh dose of dostarlimab. Six weeks ago, at the restaging visit, the tumor had almost gone on MRI and endoscopy, and levothyroxine 75 micrograms was started for immune-related hypothyroidism. She takes it on waking, four hours apart from her iron, and the tiredness and cold hands have gone. Her bowel movements are normal, with no blood, urgency or pain. She is playing 18 holes most days and finished third in a regional event last week. She has had no diarrhea, rash, cough or breathlessness since the cold in June. Her PHQ-9 today is 2.",
            "elements": [
              {
                "label": "Visit",
                "value": "Periodic adult preventive visit, age 42"
              },
              {
                "label": "Active conditions",
                "value": "Mismatch repair-deficient low rectal cancer on dostarlimab with a near-complete response; immune-related hypothyroidism on levothyroxine; iron deficiency anemia, recovering"
              },
              {
                "label": "Medicines",
                "value": "Dostarlimab every three weeks; levothyroxine 75 micrograms daily; ferrous sulfate 325 mg on alternate days; levonorgestrel intrauterine device"
              },
              {
                "label": "Mood",
                "value": "PHQ-9 2"
              }
            ]
          },
          "health_risk_assessment": [
            {
              "domain": "Self-rated health",
              "finding": "Very good"
            },
            {
              "domain": "Psychosocial",
              "finding": "Busy with tournaments and the club; worried at times that the cancer will come back; sleeps well"
            },
            {
              "domain": "Tobacco",
              "finding": "Never smoked"
            },
            {
              "domain": "Alcohol and drugs",
              "finding": "A drink once or twice a month; no drugs"
            },
            {
              "domain": "Physical activity",
              "finding": "Golf most days, walking the course; strength work three times a week"
            },
            {
              "domain": "Nutrition",
              "finding": "Has cut red meat to twice a week and eats more vegetables and whole grains"
            },
            {
              "domain": "Sun exposure",
              "finding": "Outdoors most of the day; uses sunscreen inconsistently; wears a visor"
            },
            {
              "domain": "Sexual and reproductive health",
              "finding": "Sex comfortable again since the bleeding stopped; levonorgestrel IUD in place; not planning a pregnancy"
            },
            {
              "domain": "Safety at home",
              "finding": "Feels safe; no one hurts, threatens or controls her; no firearm in the home"
            },
            {
              "domain": "Road safety",
              "finding": "Wears a seat belt; drives long distances between tournaments and stops to rest"
            },
            {
              "domain": "Activities of daily living",
              "finding": "Independent"
            }
          ],
          "ros": [
            {
              "system": "Constitutional",
              "status": "negative",
              "finding": "No fever, night sweats or weight loss; energy back to normal"
            },
            {
              "system": "Eyes",
              "status": "negative",
              "finding": "No vision change; eye examination last year"
            },
            {
              "system": "Ears, nose, mouth, and throat",
              "status": "negative",
              "finding": "No mouth sores"
            },
            {
              "system": "Cardiovascular",
              "status": "negative",
              "finding": "No chest pain or palpitations"
            },
            {
              "system": "Respiratory",
              "status": "negative",
              "finding": "No cough or breathlessness"
            },
            {
              "system": "Gastrointestinal",
              "status": "negative",
              "finding": "Normal bowel movements; no blood, urgency or pain"
            },
            {
              "system": "Genitourinary",
              "status": "negative",
              "finding": "Light periods with the IUD; no urinary symptoms"
            },
            {
              "system": "Breast",
              "status": "negative",
              "finding": "No lump or nipple discharge"
            },
            {
              "system": "Musculoskeletal",
              "status": "negative",
              "finding": "No joint pain or swelling"
            },
            {
              "system": "Integumentary",
              "status": "negative",
              "finding": "No rash or itching; no changing moles"
            },
            {
              "system": "Neurological",
              "status": "negative",
              "finding": "No headache or numbness"
            },
            {
              "system": "Endocrine",
              "status": "negative",
              "finding": "Cold intolerance gone; no thirst"
            },
            {
              "system": "Psychiatric",
              "status": "negative",
              "finding": "Mood good; PHQ-9 2; no thoughts of self-harm"
            }
          ],
          "exam": [
            {
              "system": "Constitutional",
              "finding": "Fit and well; weight 63.6 kg, BMI 22.5; blood pressure 112/68"
            },
            {
              "system": "Head, eyes, ears, nose, and throat",
              "finding": "Normal"
            },
            {
              "system": "Neck",
              "finding": "Thyroid not enlarged or tender; no lymph nodes"
            },
            {
              "system": "Breasts",
              "finding": "Examined with her agreement and a chaperone: no mass, skin change or nipple discharge; no axillary nodes"
            },
            {
              "system": "Cardiovascular",
              "finding": "Regular rhythm; no murmur"
            },
            {
              "system": "Respiratory",
              "finding": "Clear to auscultation bilaterally"
            },
            {
              "system": "Abdomen",
              "finding": "Soft, non-tender; no liver enlargement or mass"
            },
            {
              "system": "Skin",
              "finding": "Sun-damaged skin on the forearms, face and neck; several solar lentigines; no lesion suspicious for melanoma or other skin cancer"
            },
            {
              "system": "Musculoskeletal",
              "finding": "Full range of movement of the spine, shoulders and hips"
            },
            {
              "system": "Psychiatric",
              "finding": "Cheerful, quick and engaged"
            }
          ],
          "assessment_plan": [
            {
              "display": "Periodic adult preventive visit completed",
              "assessment": "Health risk assessment reviewed and the prevention plan updated for a woman of 42 on immunotherapy for rectal cancer. Breast screening is due under the current recommendation to screen every two years from 40; a mammogram was ordered. Cervical screening is up to date. Hepatitis B surface antibody was negative before treatment, so the two-dose adjuvanted hepatitis B vaccine was started today; inactivated vaccines are safe on PD-1 blockade. Influenza and COVID-19 vaccines are due when this season's vaccines arrive. Sun protection was discussed in detail because she is outdoors all day",
              "plan": [
                "Hepatitis B vaccine dose 1 today; dose 2 at cycle 9",
                "Screening mammogram ordered",
                "Influenza and COVID-19 vaccines in the autumn",
                "Broad-spectrum sunscreen of SPF 30 or more, reapplied every two hours on the course, with a wide-brimmed hat and sun sleeves",
                "Next preventive visit in one year"
              ]
            },
            {
              "problem_id": "PRB-004",
              "display": "Immune-related hypothyroidism on levothyroxine",
              "assessment": "TSH 3.1 mIU/L and free T4 1.1 ng/dL six weeks after starting levothyroxine 75 micrograms: replaced, and symptoms gone",
              "plan": [
                "Continue levothyroxine 75 micrograms on waking, four hours from iron",
                "TSH and free T4 every six weeks while on dostarlimab"
              ]
            },
            {
              "problem_id": "PRB-003",
              "display": "Mismatch repair-deficient low rectal cancer on dostarlimab",
              "assessment": "Near-complete response at three months; cycle 7 today",
              "plan": [
                "Cycles 8 and 9 as booked; final restaging after cycle 9"
              ]
            }
          ],
          "prevention_plan": [
            {
              "service": "Blood pressure screening",
              "status": "completed_today",
              "detail": "112/68 mmHg",
              "guideline_ids": [
                "GL-USPSTF-AB"
              ]
            },
            {
              "service": "Depression screening",
              "status": "completed_today",
              "detail": "PHQ-9 score 2; item 9 scored 0",
              "guideline_ids": [
                "GL-USPSTF-DEP-2023"
              ]
            },
            {
              "service": "Unhealthy alcohol use screening",
              "status": "completed_today",
              "detail": "One or two drinks a month",
              "guideline_ids": [
                "GL-USPSTF-ALC-2018"
              ]
            },
            {
              "service": "Tobacco use",
              "status": "completed_today",
              "detail": "Never smoked",
              "guideline_ids": [
                "GL-USPSTF-AB"
              ]
            },
            {
              "service": "Intimate partner violence screening",
              "status": "completed_today",
              "detail": "Negative; she feels safe",
              "guideline_ids": [
                "GL-USPSTF-IPV-2018"
              ]
            },
            {
              "service": "Breast cancer screening",
              "status": "ordered",
              "detail": "Mammogram every two years from 40; first screening mammogram ordered",
              "guideline_ids": [
                "GL-USPSTF-BRCA-2024"
              ]
            },
            {
              "service": "Cervical cancer screening",
              "status": "up_to_date",
              "detail": "HPV and cytology co-test two years ago, normal; next in three years",
              "guideline_ids": [
                "GL-USPSTF-CERV-2018"
              ]
            },
            {
              "service": "Colorectal cancer screening",
              "status": "not_indicated",
              "detail": "Screening does not apply: she is under cancer surveillance with MRI, endoscopy and colonoscopy",
              "guideline_ids": [
                "GL-USPSTF-CRC-2021",
                "GL-NCCN-RECT-2026"
              ]
            },
            {
              "service": "HIV, hepatitis B and hepatitis C screening",
              "status": "up_to_date",
              "detail": "All negative before treatment; hepatitis B surface antibody negative",
              "guideline_ids": [
                "GL-USPSTF-AB",
                "GL-ASCO-HBV-2020"
              ]
            },
            {
              "service": "Prediabetes and diabetes screening",
              "status": "not_indicated",
              "detail": "BMI 22.5 with no other risk factor; fasting glucose normal before each cycle",
              "guideline_ids": [
                "GL-USPSTF-AB"
              ]
            },
            {
              "service": "Lipid screening",
              "status": "up_to_date",
              "detail": "Lipid panel three years ago normal",
              "guideline_ids": [
                "GL-PREV-2026"
              ]
            },
            {
              "service": "Skin cancer prevention counseling",
              "status": "completed_today",
              "detail": "Sun protection for an outdoor athlete; skin examined, no suspicious lesion",
              "guideline_ids": [
                "GL-PREV-2026"
              ]
            },
            {
              "service": "Hepatitis B vaccine",
              "status": "completed_today",
              "detail": "Dose 1 of the two-dose adjuvanted series; dose 2 in one month or later",
              "guideline_ids": [
                "GL-CDC-IMZ-2026"
              ]
            },
            {
              "service": "Influenza vaccine",
              "status": "due",
              "detail": "When this season's vaccine is available",
              "guideline_ids": [
                "GL-CDC-IMZ-2026"
              ]
            },
            {
              "service": "COVID-19 vaccine",
              "status": "due",
              "detail": "This season's vaccine in the autumn",
              "guideline_ids": [
                "GL-CDC-IMZ-2026"
              ]
            },
            {
              "service": "Tetanus, diphtheria, and pertussis",
              "status": "up_to_date",
              "detail": "Tdap five years ago",
              "guideline_ids": [
                "GL-CDC-IMZ-2026"
              ]
            },
            {
              "service": "Recombinant zoster vaccine",
              "status": "not_indicated",
              "detail": "Recommended from 50, or from 19 for immunosuppression; PD-1 blockade alone is not immunosuppressive treatment",
              "guideline_ids": [
                "GL-CDC-IMZ-2026"
              ]
            },
            {
              "service": "Contraception counseling",
              "status": "completed_today",
              "detail": "Levonorgestrel IUD continued during treatment and for at least four months after the last dose",
              "guideline_ids": [
                "GL-ASCO-FERT-2018"
              ]
            },
            {
              "service": "Dental and vision examination",
              "status": "due",
              "detail": "Dental cleaning due; eye examination next year",
              "guideline_ids": [
                "GL-PREV-2026"
              ]
            }
          ],
          "advance_care_planning": "Voluntary advance care planning discussion of about 20 minutes, with her consent. She named a health care agent, recorded in the confidential part of the chart and not named here, and completed a health care proxy form. She said that she wants every treatment with a real chance of controlling the cancer, including surgery and a colostomy if the tumor ever regrows, and wants to be told the facts at once and in plain words. If she were ever too ill to decide and unlikely to recover, she would want care aimed at comfort, with her pain fully treated. To be revisited at each change in her health and at least yearly.",
          "follow_up": "Cycle 7 today; cycles 8 and 9 as booked; hepatitis B dose 2 at cycle 9; mammogram; final restaging after cycle 9. Next preventive visit in one year",
          "guideline_ids": [
            "GL-PREV-2026",
            "GL-USPSTF-AB",
            "GL-CDC-IMZ-2026",
            "GL-USPSTF-BRCA-2024",
            "GL-USPSTF-CERV-2018",
            "GL-ASCO-IRAE-2021"
          ]
        },
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic periodic preventive visit.",
          "author": "The Human Record generator",
          "created": "2026-11-05T10:30:00-05:00"
        }
      }
    ],
    "vital_sign_sets": [
      {
        "id": "VSET-001",
        "date": "2026-03-16",
        "measurements": [
          {
            "code": "8302-2",
            "display": "Body height",
            "value": 168,
            "unit": "cm"
          },
          {
            "code": "29463-7",
            "display": "Body weight",
            "value": 62.8,
            "unit": "kg"
          },
          {
            "code": "39156-5",
            "display": "Body mass index (BMI) [Ratio]",
            "value": 22.3,
            "unit": "kg/m2"
          },
          {
            "code": "8480-6",
            "display": "Systolic blood pressure",
            "value": 112,
            "unit": "mm[Hg]"
          },
          {
            "code": "8462-4",
            "display": "Diastolic blood pressure",
            "value": 70,
            "unit": "mm[Hg]"
          },
          {
            "code": "8867-4",
            "display": "Heart rate",
            "value": 86,
            "unit": "/min"
          },
          {
            "code": "9279-1",
            "display": "Respiratory rate",
            "value": 14,
            "unit": "/min"
          },
          {
            "code": "8310-5",
            "display": "Body temperature",
            "value": 36.7,
            "unit": "Cel"
          },
          {
            "code": "59408-5",
            "display": "Oxygen saturation in Arterial blood by Pulse oximetry",
            "value": 99,
            "unit": "%"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic vital signs at presentation; no measurement from her life is used.",
          "author": "The Human Record generator",
          "created": "2026-11-05T10:00:00-05:00"
        }
      },
      {
        "id": "VSET-002",
        "date": "2026-03-30",
        "measurements": [
          {
            "code": "8302-2",
            "display": "Body height",
            "value": 168,
            "unit": "cm"
          },
          {
            "code": "29463-7",
            "display": "Body weight",
            "value": 62.6,
            "unit": "kg"
          },
          {
            "code": "39156-5",
            "display": "Body mass index (BMI) [Ratio]",
            "value": 22.2,
            "unit": "kg/m2"
          },
          {
            "code": "8480-6",
            "display": "Systolic blood pressure",
            "value": 116,
            "unit": "mm[Hg]"
          },
          {
            "code": "8462-4",
            "display": "Diastolic blood pressure",
            "value": 72,
            "unit": "mm[Hg]"
          },
          {
            "code": "8867-4",
            "display": "Heart rate",
            "value": 80,
            "unit": "/min"
          },
          {
            "code": "9279-1",
            "display": "Respiratory rate",
            "value": 14,
            "unit": "/min"
          },
          {
            "code": "8310-5",
            "display": "Body temperature",
            "value": 36.6,
            "unit": "Cel"
          },
          {
            "code": "59408-5",
            "display": "Oxygen saturation in Arterial blood by Pulse oximetry",
            "value": 99,
            "unit": "%"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic seated vital signs; no measurement from her life is used.",
          "author": "The Human Record generator",
          "created": "2026-11-05T10:00:00-05:00"
        }
      },
      {
        "id": "VSET-003",
        "date": "2026-04-27",
        "measurements": [
          {
            "code": "8302-2",
            "display": "Body height",
            "value": 168,
            "unit": "cm"
          },
          {
            "code": "29463-7",
            "display": "Body weight",
            "value": 63.2,
            "unit": "kg"
          },
          {
            "code": "39156-5",
            "display": "Body mass index (BMI) [Ratio]",
            "value": 22.4,
            "unit": "kg/m2"
          },
          {
            "code": "8480-6",
            "display": "Systolic blood pressure",
            "value": 110,
            "unit": "mm[Hg]"
          },
          {
            "code": "8462-4",
            "display": "Diastolic blood pressure",
            "value": 68,
            "unit": "mm[Hg]"
          },
          {
            "code": "8867-4",
            "display": "Heart rate",
            "value": 70,
            "unit": "/min"
          },
          {
            "code": "9279-1",
            "display": "Respiratory rate",
            "value": 14,
            "unit": "/min"
          },
          {
            "code": "8310-5",
            "display": "Body temperature",
            "value": 36.6,
            "unit": "Cel"
          },
          {
            "code": "59408-5",
            "display": "Oxygen saturation in Arterial blood by Pulse oximetry",
            "value": 99,
            "unit": "%"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic seated vital signs; no measurement from her life is used.",
          "author": "The Human Record generator",
          "created": "2026-11-05T10:00:00-05:00"
        }
      },
      {
        "id": "VSET-004",
        "date": "2026-06-29",
        "measurements": [
          {
            "code": "8302-2",
            "display": "Body height",
            "value": 168,
            "unit": "cm"
          },
          {
            "code": "29463-7",
            "display": "Body weight",
            "value": 63.8,
            "unit": "kg"
          },
          {
            "code": "39156-5",
            "display": "Body mass index (BMI) [Ratio]",
            "value": 22.6,
            "unit": "kg/m2"
          },
          {
            "code": "8480-6",
            "display": "Systolic blood pressure",
            "value": 114,
            "unit": "mm[Hg]"
          },
          {
            "code": "8462-4",
            "display": "Diastolic blood pressure",
            "value": 72,
            "unit": "mm[Hg]"
          },
          {
            "code": "8867-4",
            "display": "Heart rate",
            "value": 60,
            "unit": "/min"
          },
          {
            "code": "9279-1",
            "display": "Respiratory rate",
            "value": 14,
            "unit": "/min"
          },
          {
            "code": "8310-5",
            "display": "Body temperature",
            "value": 36.4,
            "unit": "Cel"
          },
          {
            "code": "59408-5",
            "display": "Oxygen saturation in Arterial blood by Pulse oximetry",
            "value": 99,
            "unit": "%"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic seated vital signs; no measurement from her life is used.",
          "author": "The Human Record generator",
          "created": "2026-11-05T10:00:00-05:00"
        }
      },
      {
        "id": "VSET-005",
        "date": "2026-10-05",
        "measurements": [
          {
            "code": "8302-2",
            "display": "Body height",
            "value": 168,
            "unit": "cm"
          },
          {
            "code": "29463-7",
            "display": "Body weight",
            "value": 63.4,
            "unit": "kg"
          },
          {
            "code": "39156-5",
            "display": "Body mass index (BMI) [Ratio]",
            "value": 22.5,
            "unit": "kg/m2"
          },
          {
            "code": "8480-6",
            "display": "Systolic blood pressure",
            "value": 112,
            "unit": "mm[Hg]"
          },
          {
            "code": "8462-4",
            "display": "Diastolic blood pressure",
            "value": 70,
            "unit": "mm[Hg]"
          },
          {
            "code": "8867-4",
            "display": "Heart rate",
            "value": 64,
            "unit": "/min"
          },
          {
            "code": "9279-1",
            "display": "Respiratory rate",
            "value": 14,
            "unit": "/min"
          },
          {
            "code": "8310-5",
            "display": "Body temperature",
            "value": 36.6,
            "unit": "Cel"
          },
          {
            "code": "59408-5",
            "display": "Oxygen saturation in Arterial blood by Pulse oximetry",
            "value": 99,
            "unit": "%"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic seated vital signs; no measurement from her life is used.",
          "author": "The Human Record generator",
          "created": "2026-11-05T10:00:00-05:00"
        }
      },
      {
        "id": "VSET-006",
        "date": "2026-06-01",
        "measurements": [
          {
            "code": "8302-2",
            "display": "Body height",
            "value": 168,
            "unit": "cm"
          },
          {
            "code": "29463-7",
            "display": "Body weight",
            "value": 63.0,
            "unit": "kg"
          },
          {
            "code": "39156-5",
            "display": "Body mass index (BMI) [Ratio]",
            "value": 22.3,
            "unit": "kg/m2"
          },
          {
            "code": "8480-6",
            "display": "Systolic blood pressure",
            "value": 114,
            "unit": "mm[Hg]"
          },
          {
            "code": "8462-4",
            "display": "Diastolic blood pressure",
            "value": 70,
            "unit": "mm[Hg]"
          },
          {
            "code": "8867-4",
            "display": "Heart rate",
            "value": 88,
            "unit": "/min"
          },
          {
            "code": "9279-1",
            "display": "Respiratory rate",
            "value": 16,
            "unit": "/min"
          },
          {
            "code": "8310-5",
            "display": "Body temperature",
            "value": 37.9,
            "unit": "Cel"
          },
          {
            "code": "59408-5",
            "display": "Oxygen saturation in Arterial blood by Pulse oximetry",
            "value": 98,
            "unit": "%"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic vital signs at the sick visit: low-grade fever; normal oxygen saturation at rest and after walking.",
          "author": "The Human Record generator",
          "created": "2026-11-05T10:30:00-05:00"
        }
      },
      {
        "id": "VSET-007",
        "date": "2026-08-10",
        "measurements": [
          {
            "code": "8302-2",
            "display": "Body height",
            "value": 168,
            "unit": "cm"
          },
          {
            "code": "29463-7",
            "display": "Body weight",
            "value": 63.6,
            "unit": "kg"
          },
          {
            "code": "39156-5",
            "display": "Body mass index (BMI) [Ratio]",
            "value": 22.5,
            "unit": "kg/m2"
          },
          {
            "code": "8480-6",
            "display": "Systolic blood pressure",
            "value": 112,
            "unit": "mm[Hg]"
          },
          {
            "code": "8462-4",
            "display": "Diastolic blood pressure",
            "value": 68,
            "unit": "mm[Hg]"
          },
          {
            "code": "8867-4",
            "display": "Heart rate",
            "value": 62,
            "unit": "/min"
          },
          {
            "code": "9279-1",
            "display": "Respiratory rate",
            "value": 14,
            "unit": "/min"
          },
          {
            "code": "8310-5",
            "display": "Body temperature",
            "value": 36.5,
            "unit": "Cel"
          },
          {
            "code": "59408-5",
            "display": "Oxygen saturation in Arterial blood by Pulse oximetry",
            "value": 99,
            "unit": "%"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic seated vital signs at the preventive visit.",
          "author": "The Human Record generator",
          "created": "2026-11-05T10:30:00-05:00"
        }
      }
    ],
    "social_history": [
      {
        "id": "SOC-001",
        "display": "Professional golfer who plays tournaments and exhibitions and practices most days; an Olympic track and field champion in her youth; has never had colorectal cancer screening, which was not yet due at her age",
        "status": "current",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0003",
            "CLM-0005"
          ],
          "synthetic_reason": "Synthetic modern work history anchored to her documented athletic career.",
          "author": "The Human Record generator",
          "created": "2026-11-05T10:00:00-05:00"
        }
      },
      {
        "id": "SOC-002",
        "display": "Married, with no children; lives at the golf club she owns in Tampa, Florida, and keeps close ties to her family in Beaumont, Texas. No relative or companion is named or given a role in her care",
        "status": "current",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0004",
            "CLM-0005"
          ],
          "synthetic_reason": "Synthetic household anchored to her documented marriage and the Tampa club; no real person is given a role.",
          "author": "The Human Record generator",
          "created": "2026-11-05T10:00:00-05:00"
        }
      },
      {
        "id": "SOC-003",
        "display": "Never smoker; alcohol rarely; no drug use; eats a varied diet with red meat most days",
        "status": "current",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic substance and diet history for the modern episode; her real use was not researched and is not used.",
          "author": "The Human Record generator",
          "created": "2026-11-05T10:00:00-05:00"
        }
      },
      {
        "id": "SOC-004",
        "display": "Periods regular; a levonorgestrel intrauterine device for contraception, placed three years ago; not planning a pregnancy; sexually active, with pain during sex and bleeding afterwards in recent weeks",
        "status": "current",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic reproductive and sexual history; not a historical assertion.",
          "author": "The Human Record generator",
          "created": "2026-11-05T10:00:00-05:00"
        }
      },
      {
        "id": "SOC-005",
        "display": "Fiercely competitive and direct; wants plain facts, and wants to know what any treatment would mean for her game and whether she would need a bag",
        "status": "current",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0003",
            "CLM-0005"
          ],
          "synthetic_reason": "Synthetic preference anchored to her documented competitive career.",
          "author": "The Human Record generator",
          "created": "2026-11-05T10:00:00-05:00"
        }
      }
    ],
    "functional_status": [
      {
        "id": "FUNC-001",
        "display": "Fully active; plays 18 holes and practices daily, though tired by the back nine for some months (ECOG performance status 0)",
        "status": "current",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0006"
          ],
          "synthetic_reason": "Synthetic functional status at presentation.",
          "author": "The Human Record generator",
          "created": "2026-11-05T10:00:00-05:00"
        }
      }
    ],
    "mental_status": [
      {
        "id": "MSE-001",
        "display": "Alert, quick and humorous; worried underneath; PHQ-2 negative; no thoughts of self-harm",
        "status": "current",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic mental-status finding; not a claim about her real mental state.",
          "author": "The Human Record generator",
          "created": "2026-11-05T10:00:00-05:00"
        }
      }
    ],
    "consultation": {
      "referral": {
        "question": "Suspected low rectal cancer in a 41-year-old professional golfer with three months of rectal bleeding, narrower stools, urgency and tenesmus, a firm ulcerated mass felt on the posterior wall of the lower rectum at about 5 cm, iron deficiency anemia (hemoglobin 11.0 g/dL, ferritin 9 ng/mL) and CEA 5.8 ng/mL. Colonoscopy with biopsy is booked this week. Please see her within two weeks, with colorectal surgery, to review the results with her and plan staging and treatment if cancer is found",
        "urgency": "Urgent, within two weeks",
        "pertinent_history": "Bright red blood with most bowel movements for about three months, narrower stools, urgency and a feeling of incomplete emptying; more tired than usual since the end of last season. A walk-in clinic treated it as hemorrhoids two months ago without an examination. Weight 62.8 kg; pulse 86; abdomen normal; on rectal examination a firm, ulcerated, partly mobile mass on the posterior wall with its lower edge about 5 cm from the anal verge, sphincter tone normal, blood on the glove; no inguinal nodes. Results today: hemoglobin 11.0 g/dL, MCV 77 fL, ferritin 9 ng/mL, platelets 412; creatinine 0.78 mg/dL; liver tests and albumin normal; CEA 5.8 ng/mL. No regular medicines; levonorgestrel IUD; no known allergies. Never smoker. She knows of no colorectal cancer in her family; family history not otherwise known. She is a professional golfer and former Olympic athlete who wants to keep competing and wants to know at once whether she would need a colostomy",
        "questions": [
          "What is the diagnosis and its stage, and what further tests are needed?",
          "What treatment do you recommend, in what order, and can her rectum and anal sphincter be kept?",
          "What genetic testing is needed, on the tumor and on her blood, and what would the results mean for her and her family?",
          "What side effects should primary care watch for during treatment, and what monitoring should we share?",
          "Can she keep training and competing during treatment, and what should she know about sexual health, contraception and fertility?"
        ]
      },
      "consultant_note": {
        "history": "Ms. Didrikson Zaharias, 41, is seen at the request of Dr. Vasquez-Thornbury two weeks after she presented with three months of rectal bleeding, a change in bowel habit and a rectal mass. Since then she has had a colonoscopy with biopsy, rectal-protocol MRI, CT of the chest, abdomen and pelvis, and review at our colorectal tumor board. She still passes a little bright red blood most days, with urgency, and tires late in a round. She has pain during sex and spotting afterwards. She is fully active (ECOG 0), has a levonorgestrel IUD and is not planning a pregnancy. She was seen by the colorectal surgeon this morning. She asked whether she would need a colostomy and whether she could keep playing",
        "data_reviewed": "Dr. Vasquez-Thornbury's intake note and results. Colonoscopy: ulcerated mass on the posterior and left wall of the lower rectum, 4 to 9 cm from the anal verge, about half the circumference; the rest of the colon normal. Pathology: adenocarcinoma, moderately differentiated; loss of MSH2 and MSH6 on immunohistochemistry with MLH1 and PMS2 retained; microsatellite instability high. Rectal-protocol MRI: tumor extending 4 mm beyond the muscularis propria (cT3b), two irregular 7 mm mesorectal nodes (cN1), mesorectal fascia clear by 6 mm, no extramural venous invasion, lower edge about 1 cm above the anorectal junction, sphincters not involved. CT of the chest, abdomen and pelvis: no metastases. CEA 5.8 ng/mL at the first visit. Today: hemoglobin 11.1 g/dL, platelets 405, creatinine 0.76 mg/dL, ALT 17 and AST 20 U/L, glucose 90 mg/dL, TSH 1.9 mIU/L, free T4 1.2 ng/dL; urine pregnancy test negative",
        "exam": [
          {
            "system": "General",
            "finding": "Fit and composed; weight 62.6 kg; blood pressure 116/72, pulse 80; ECOG 0"
          },
          {
            "system": "Abdomen",
            "finding": "Soft, non-tender; no liver enlargement"
          },
          {
            "system": "Lymph nodes",
            "finding": "No inguinal or supraclavicular nodes"
          },
          {
            "system": "Rectal",
            "finding": "Firm, ulcerated mass on the posterior and left wall, lower edge about 4 to 5 cm from the anal verge; normal sphincter tone"
          }
        ],
        "assessment": [
          {
            "problem_id": "PRB-003",
            "display": "Low rectal adenocarcinoma, mismatch repair deficient, cT3bN1M0 (stage IIIB)",
            "assessment": "Locally advanced adenocarcinoma of the low rectum with no distant spread. For a mismatch repair-proficient tumor at this level the standard would be total neoadjuvant therapy (chemoradiation and chemotherapy) followed by total mesorectal excision, and because the lower edge is only about 1 cm above the anorectal junction the operation would most likely be an abdominoperineal resection with a permanent colostomy. This tumor is mismatch repair deficient, which changes everything: in the dostarlimab trial every patient with this kind of tumor who completed six months of treatment had a clinical complete response, and in the larger follow-up study nearly all kept their rectum without radiation or surgery, with few regrowths. The NCCN and ASCO guidelines now recommend checkpoint inhibitor immunotherapy for mismatch repair-deficient locally advanced rectal cancer. The aim is cure with the rectum and sphincter preserved; radiation and surgery remain available if the response is incomplete or the tumor regrows"
          },
          {
            "problem_id": "PRB-002",
            "display": "Iron deficiency anemia from blood loss",
            "assessment": "From the tumor's bleeding; oral iron is enough while the bleeding settles with treatment"
          }
        ],
        "recommendations": [
          "Dostarlimab 500 mg intravenously every three weeks for nine doses (six months), starting next week",
          "Restaging with rectal-protocol MRI, flexible sigmoidoscopy and digital rectal examination after about three months and again after the last dose, with CT of the chest, abdomen and pelvis at the end; CEA at each restaging",
          "If there is a clinical complete response at the end of treatment, watch-and-wait: examination and sigmoidoscopy every three to four months and MRI every six months for two years, CEA every three to six months, CT every six to twelve months, and colonoscopy at one year",
          "If the response is incomplete, chemoradiation and total mesorectal excision, with stoma site marking and teaching by the wound-ostomy nurse before any operation; no stoma preparation is needed now",
          "Germline multigene panel after genetic counseling, because she is under 50 and the tumor is mismatch repair deficient; if negative, tumor sequencing for somatic MSH2 or MSH6 variants. Her first-degree relatives should start colonoscopy at 40, or 10 years before her age at diagnosis if earlier, every five years, with more intensive Lynch syndrome surveillance only if a germline variant is found",
          "Before the first dose: hepatitis B, hepatitis C and HIV screening, a pregnancy test, and baseline TSH, free T4, liver and kidney tests and glucose",
          "During treatment, primary care to watch for immune-related adverse events, the commonest being thyroid inflammation: TSH and free T4 every six weeks, liver and kidney tests and glucose before each dose, and same-day review for diarrhea, blood in the stool, rash, cough, breathlessness, headache, thirst or unusual tiredness",
          "Oral iron for the anemia, with a blood count in four weeks",
          "She can keep training and competing; dostarlimab does not limit exercise. Contraception with her IUD during treatment and for four months after the last dose; dostarlimab is not known to harm fertility. Sexual pain and spotting should settle as the tumor responds",
          "Distress screening at each visit; she decides who receives these notes"
        ],
        "communication": "Discussed with Dr. Vasquez-Thornbury and presented at the colorectal tumor board with colorectal surgery, radiation oncology, radiology, pathology and genetics. The images, the biopsy and the meaning of mismatch repair deficiency were explained to Ms. Didrikson Zaharias in plain words, including that surgery would most likely mean a permanent colostomy and that immunotherapy offers a good chance of avoiding it. She chose dostarlimab with watch-and-wait if the response is complete. She decides who else receives this note",
        "follow_up": "Cycle 1 next week; oncology review before each dose; restaging after four doses and after nine; Dr. Vasquez-Thornbury continues primary care and shares the monitoring"
      },
      "guideline_ids": [
        "GL-NCCN-RECT-2026",
        "GL-ASCO-LARC-2024",
        "GL-CERCEK-2022",
        "GL-CERCEK-2025",
        "GL-ASCO-IRAE-2021",
        "GL-ASCO-GERM-2024",
        "GL-USMSTF-2017",
        "GL-ASCO-HBV-2020",
        "GL-ASCO-FERT-2018",
        "GL-ASCO-EX-2022"
      ]
    }
  },
  "care_plan": {
    "health_concerns": [
      {
        "id": "HC-001",
        "display": "Bright red blood with most bowel movements for about three months, stools narrower than before, urgency and a feeling of not having finished; more tired than usual on the course since the end of last season",
        "status": "active",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0006"
          ],
          "synthetic_reason": "Synthetic presenting concern anchored to the documented fatigue at the end of the 1952 season.",
          "author": "The Human Record generator",
          "created": "2026-11-05T10:00:00-05:00"
        }
      },
      {
        "id": "HC-002",
        "display": "A walk-in clinic put the bleeding down to hemorrhoids two months ago and gave her a cream; she is 41, below the age at which screening starts, and was not examined",
        "status": "active",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic concern illustrating the delays in diagnosis of colorectal cancer in adults under 50.",
          "author": "The Human Record generator",
          "created": "2026-11-05T10:00:00-05:00"
        }
      },
      {
        "id": "HC-003",
        "display": "She wants to keep competing, and wants to know at once whether whatever this is will mean a colostomy",
        "status": "active",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0003",
            "CLM-0005"
          ],
          "synthetic_reason": "Synthetic concern anchored to her documented career.",
          "author": "The Human Record generator",
          "created": "2026-11-05T10:00:00-05:00"
        }
      }
    ],
    "goals": [
      {
        "id": "GOAL-001",
        "display": "Colonoscopy within one week, staging within two weeks, and a tumor board plan before treatment",
        "status": "completed",
        "target_date": "2026-03-30",
        "outcome": "Colonoscopy in three days, MRI and CT within nine days, tumor board in eleven days, consultation at two weeks",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic diagnostic-pathway goal.",
          "author": "The Human Record generator",
          "created": "2026-11-05T10:00:00-05:00"
        }
      },
      {
        "id": "GOAL-002",
        "display": "Germline genetic testing with counseling, and an explanation of the mismatch repair deficiency, within four weeks of diagnosis",
        "status": "completed",
        "target_date": "2026-04-27",
        "outcome": "Germline panel negative; two somatic MSH2 variants in the tumor explain the deficiency",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic genetics goal.",
          "author": "The Human Record generator",
          "created": "2026-11-05T10:00:00-05:00"
        }
      },
      {
        "id": "GOAL-003",
        "display": "Clinical complete response after six months of dostarlimab, with the rectum and sphincter preserved",
        "status": "completed",
        "target_date": "2026-10-05",
        "outcome": "Clinical complete response on MRI, endoscopy and examination after nine doses; watch-and-wait begun",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic treatment goal.",
          "author": "The Human Record generator",
          "created": "2026-11-05T10:00:00-05:00"
        }
      },
      {
        "id": "GOAL-004",
        "display": "Hemoglobin of 12 g/dL or more and ferritin above 30 ng/mL",
        "status": "completed",
        "target_date": "2026-10-05",
        "outcome": "Hemoglobin 13.4 g/dL and ferritin 41 ng/mL",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic anemia goal.",
          "author": "The Human Record generator",
          "created": "2026-11-05T10:00:00-05:00"
        }
      },
      {
        "id": "GOAL-005",
        "display": "Back to tournament golf during treatment",
        "status": "completed",
        "target_date": "2026-06-29",
        "outcome": "Playing 18 holes and entered in a club competition by the fourth visit",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic sport goal.",
          "author": "The Human Record generator",
          "created": "2026-11-05T10:00:00-05:00"
        }
      },
      {
        "id": "GOAL-006",
        "display": "TSH within the reference range on thyroid replacement",
        "status": "completed",
        "target_date": "2026-08-10",
        "outcome": "TSH 3.1 mIU/L six weeks after levothyroxine began",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic immune-related adverse event goal.",
          "author": "The Human Record generator",
          "created": "2026-11-05T10:00:00-05:00"
        }
      },
      {
        "id": "GOAL-007",
        "display": "PHQ-9 below 10 throughout treatment",
        "status": "completed",
        "target_date": "2026-10-05",
        "outcome": "PHQ-9 between 2 and 6",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic psychosocial goal.",
          "author": "The Human Record generator",
          "created": "2026-11-05T10:00:00-05:00"
        }
      }
    ],
    "interventions": [
      {
        "id": "INT-001",
        "display": "Medical oncology (gastrointestinal) consultation within two weeks, with colorectal surgery, to review the colonoscopy and any biopsy with her and plan staging and treatment if cancer is found",
        "status": "completed",
        "guideline_ids": [
          "GL-NCCN-RECT-2026",
          "GL-ASCO-LARC-2024"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0006"
          ],
          "synthetic_reason": "Synthetic specialist consultation booked at intake so that a positive biopsy reaches a specialist without delay.",
          "author": "The Human Record generator",
          "created": "2026-11-05T10:00:00-05:00"
        }
      },
      {
        "id": "INT-002",
        "display": "Urgent work-up of rectal bleeding with a change in bowel habit and a rectal mass in a woman under 50: colonoscopy with biopsy within days, with mismatch repair testing of any cancer; blood count, ferritin, chemistry and CEA; if cancer is confirmed, rectal-protocol MRI of the pelvis and CT of the chest, abdomen and pelvis; return at once for heavy bleeding, fainting or inability to pass stool",
        "status": "completed",
        "guideline_ids": [
          "GL-NCCN-RECT-2026",
          "GL-USPSTF-CRC-2021"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0006"
          ],
          "synthetic_reason": "Synthetic diagnostic pathway; it guards against the delays common in adults under the screening age.",
          "author": "The Human Record generator",
          "created": "2026-11-05T10:00:00-05:00"
        }
      },
      {
        "id": "INT-003",
        "display": "Oral iron for iron deficiency anemia from blood loss: ferrous sulfate 325 mg on alternate days, a blood count about four weeks after starting, ferritin at about three months, and iron continued for three months after the hemoglobin is normal",
        "status": "completed",
        "guideline_ids": [
          "GL-CMID-2026"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007",
            "CLM-0012"
          ],
          "synthetic_reason": "Synthetic anemia plan decided when the blood results were reviewed at the diagnosis visit.",
          "author": "The Human Record generator",
          "created": "2026-11-05T10:00:00-05:00"
        },
        "recorded_date": "2026-03-30"
      },
      {
        "id": "INT-004",
        "display": "Germline multigene panel after genetic counseling, because she is under 50 and the tumor is mismatch repair deficient; tumor sequencing for somatic MMR variants if the germline panel is negative; colonoscopy for her first-degree relatives every five years from age 40, or 10 years before the age of her diagnosis if earlier, with Lynch syndrome surveillance only if a germline variant is found",
        "status": "completed",
        "guideline_ids": [
          "GL-ASCO-GERM-2024",
          "GL-NCCN-RECT-2026",
          "GL-USMSTF-2017"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007",
            "CLM-0012"
          ],
          "synthetic_reason": "Synthetic genetics plan decided at the diagnosis visit.",
          "author": "The Human Record generator",
          "created": "2026-11-05T10:00:00-05:00"
        },
        "recorded_date": "2026-03-30"
      },
      {
        "id": "INT-005",
        "display": "Dostarlimab 500 mg intravenously every three weeks for nine doses (six months), with pelvic MRI, flexible sigmoidoscopy and digital rectal examination about every three months; blood count, kidney and liver tests and glucose before each dose and TSH with free T4 every six weeks; teaching about immune-related adverse events with a 24-hour line; hepatitis B, hepatitis C and HIV screening and a pregnancy test first; contraception continued during treatment and for four months after",
        "status": "completed",
        "guideline_ids": [
          "GL-NCCN-RECT-2026",
          "GL-ASCO-LARC-2024",
          "GL-CERCEK-2022",
          "GL-CERCEK-2025",
          "GL-ASCO-IRAE-2021",
          "GL-ASCO-HBV-2020"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007",
            "CLM-0012"
          ],
          "synthetic_reason": "Synthetic treatment chosen at the tumor board for mismatch repair-deficient locally advanced rectal cancer.",
          "author": "The Human Record generator",
          "created": "2026-11-05T10:00:00-05:00"
        },
        "recorded_date": "2026-03-30"
      },
      {
        "id": "INT-006",
        "display": "If the response is incomplete: chemoradiation and total mesorectal excision, as reviewed with the colorectal surgeon, with stoma site marking and teaching by a wound-ostomy nurse before any operation; fertility and sexual function counseling before any pelvic radiation",
        "status": "completed",
        "guideline_ids": [
          "GL-NCCN-RECT-2026",
          "GL-ASCO-LARC-2024",
          "GL-ASCO-FERT-2018"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007",
            "CLM-0012"
          ],
          "synthetic_reason": "Synthetic contingency plan decided at the diagnosis visit; not needed.",
          "author": "The Human Record generator",
          "created": "2026-11-05T10:00:00-05:00"
        },
        "recorded_date": "2026-03-30"
      },
      {
        "id": "INT-007",
        "display": "Levothyroxine for immune-related hypothyroidism, with TSH and free T4 six weeks after starting and every six weeks while on PD-1 blockade; dostarlimab continued",
        "status": "completed",
        "guideline_ids": [
          "GL-ASCO-IRAE-2021",
          "GL-CMID-2026"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007",
            "CLM-0012"
          ],
          "synthetic_reason": "Synthetic adverse-event plan decided at the fourth visit.",
          "author": "The Human Record generator",
          "created": "2026-11-05T10:00:00-05:00"
        },
        "recorded_date": "2026-06-29"
      },
      {
        "id": "INT-008",
        "display": "Watch-and-wait after a clinical complete response: digital rectal examination and flexible sigmoidoscopy every three to four months and pelvic MRI every six months for two years, CEA every three to six months, CT of the chest, abdomen and pelvis every six to twelve months, colonoscopy at one year, and a written survivorship care plan; surgery at once for any regrowth",
        "status": "completed",
        "guideline_ids": [
          "GL-NCCN-RECT-2026",
          "GL-CMID-2026",
          "GL-CERCEK-2025"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007",
            "CLM-0012"
          ],
          "synthetic_reason": "Synthetic surveillance plan decided at the final restaging visit.",
          "author": "The Human Record generator",
          "created": "2026-11-05T10:00:00-05:00"
        },
        "recorded_date": "2026-10-05"
      },
      {
        "id": "INT-009",
        "display": "Distress and depression screening at each visit; plain explanations with written information; attention to sexual health and body image and to her golf, with an exercise plan she sets; she decides who is told and who receives each note",
        "status": "completed",
        "guideline_ids": [
          "GL-USPSTF-DEP-2023",
          "GL-ASCO-EX-2022"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0006"
          ],
          "synthetic_reason": "Synthetic psychosocial plan.",
          "author": "The Human Record generator",
          "created": "2026-11-05T10:00:00-05:00"
        }
      }
    ],
    "guidelines": [
      {
        "guideline_id": "GL-NCCN-RECT-2026",
        "title": "NCCN Clinical Practice Guidelines in Oncology: Rectal Cancer (current version); summarized in Benson AB, et al. NCCN Guidelines Insights: Rectal Cancer, Version 3.2024. J Natl Compr Canc Netw 2024;22(6):366-375 (PMID 39151454)",
        "publisher": "National Comprehensive Cancer Network",
        "url": "https://pubmed.ncbi.nlm.nih.gov/39151454/",
        "version_or_year": "2026"
      },
      {
        "guideline_id": "GL-ASCO-LARC-2024",
        "title": "Scott AJ, et al. Management of Locally Advanced Rectal Cancer: ASCO Guideline. J Clin Oncol 2024;42(28):3355-3375 (PMID 39116386)",
        "publisher": "American Society of Clinical Oncology",
        "url": "https://pubmed.ncbi.nlm.nih.gov/39116386/",
        "version_or_year": "2024"
      },
      {
        "guideline_id": "GL-CERCEK-2022",
        "title": "Cercek A, et al. PD-1 Blockade in Mismatch Repair-Deficient, Locally Advanced Rectal Cancer. N Engl J Med 2022;386(25):2363-2376 (PMID 35660797)",
        "publisher": "New England Journal of Medicine",
        "url": "https://pubmed.ncbi.nlm.nih.gov/35660797/",
        "version_or_year": "2022"
      },
      {
        "guideline_id": "GL-CERCEK-2025",
        "title": "Cercek A, et al. Nonoperative Management of Mismatch Repair-Deficient Tumors. N Engl J Med 2025;392(23):2297-2308 (PMID 40293177)",
        "publisher": "New England Journal of Medicine",
        "url": "https://pubmed.ncbi.nlm.nih.gov/40293177/",
        "version_or_year": "2025"
      },
      {
        "guideline_id": "GL-ASCO-IRAE-2021",
        "title": "Schneider BJ, et al. Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: ASCO Guideline Update. J Clin Oncol 2021;39(36):4073-4126 (PMID 34724392)",
        "publisher": "American Society of Clinical Oncology",
        "url": "https://pubmed.ncbi.nlm.nih.gov/34724392/",
        "version_or_year": "2021"
      },
      {
        "guideline_id": "GL-ASCO-GERM-2024",
        "title": "Tung N, et al. Selection of Germline Genetic Testing Panels in Patients With Cancer: ASCO Guideline. J Clin Oncol 2024;42(21):2599-2615 (PMID 38759122)",
        "publisher": "American Society of Clinical Oncology",
        "url": "https://pubmed.ncbi.nlm.nih.gov/38759122/",
        "version_or_year": "2024"
      },
      {
        "guideline_id": "GL-USMSTF-2017",
        "title": "Rex DK, et al. Colorectal Cancer Screening: Recommendations for Physicians and Patients from the U.S. Multi-Society Task Force on Colorectal Cancer. Am J Gastroenterol 2017;112(7):1016-1030 (PMID 28555630)",
        "publisher": "U.S. Multi-Society Task Force on Colorectal Cancer",
        "url": "https://pubmed.ncbi.nlm.nih.gov/28555630/",
        "version_or_year": "2017"
      },
      {
        "guideline_id": "GL-USPSTF-CRC-2021",
        "title": "Colorectal Cancer: Screening (JAMA 2021;325(19):1965-1977, PMID 34003218)",
        "publisher": "U.S. Preventive Services Task Force",
        "url": "https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/colorectal-cancer-screening",
        "version_or_year": "2021"
      },
      {
        "guideline_id": "GL-ASCO-HBV-2020",
        "title": "Hwang JP, et al. Hepatitis B Virus Screening and Management for Patients With Cancer Prior to Therapy: ASCO Provisional Clinical Opinion Update. J Clin Oncol 2020;38(31):3698-3715 (PMID 32716741)",
        "publisher": "American Society of Clinical Oncology",
        "url": "https://pubmed.ncbi.nlm.nih.gov/32716741/",
        "version_or_year": "2020"
      },
      {
        "guideline_id": "GL-ASCO-FERT-2018",
        "title": "Oktay K, et al. Fertility Preservation in Patients With Cancer: ASCO Clinical Practice Guideline Update. J Clin Oncol 2018;36(19):1994-2001 (PMID 29620997)",
        "publisher": "American Society of Clinical Oncology",
        "url": "https://pubmed.ncbi.nlm.nih.gov/29620997/",
        "version_or_year": "2018"
      },
      {
        "guideline_id": "GL-ASCO-EX-2022",
        "title": "Ligibel JA, et al. Exercise, Diet, and Weight Management During Cancer Treatment: ASCO Guideline. J Clin Oncol 2022;40(22):2491-2507 (PMID 35576506)",
        "publisher": "American Society of Clinical Oncology",
        "url": "https://pubmed.ncbi.nlm.nih.gov/35576506/",
        "version_or_year": "2022"
      },
      {
        "guideline_id": "GL-CMID-2026",
        "title": "CMID: Clinical Monitoring Intelligence Database, colorectal cancer, hypothyroidism and anemia monographs",
        "publisher": "Aether Forge",
        "url": "https://patrickrutledge.github.io/topthirty/",
        "version_or_year": "2026"
      },
      {
        "guideline_id": "GL-USPSTF-DEP-2023",
        "title": "Depression and Suicide Risk in Adults: Screening",
        "publisher": "U.S. Preventive Services Task Force",
        "url": "https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/screening-depression-suicide-risk-adults",
        "version_or_year": "2023"
      },
      {
        "guideline_id": "GL-PREV-2026",
        "title": "Medicare Preventive Services reference: visit templates, screening cascades, and documentation elements",
        "publisher": "Aether Forge",
        "url": "https://patrickrutledge.github.io/preventative_services/",
        "version_or_year": "2026"
      },
      {
        "guideline_id": "GL-USPSTF-AB",
        "title": "USPSTF A and B Recommendations",
        "publisher": "U.S. Preventive Services Task Force",
        "url": "https://www.uspreventiveservicestaskforce.org/uspstf/recommendation-topics/uspstf-a-and-b-recommendations",
        "version_or_year": "2026"
      },
      {
        "guideline_id": "GL-USPSTF-BRCA-2024",
        "title": "Breast Cancer: Screening",
        "publisher": "U.S. Preventive Services Task Force",
        "url": "https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/breast-cancer-screening",
        "version_or_year": "2024"
      },
      {
        "guideline_id": "GL-USPSTF-CERV-2018",
        "title": "Cervical Cancer: Screening",
        "publisher": "U.S. Preventive Services Task Force",
        "url": "https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/cervical-cancer-screening",
        "version_or_year": "2018"
      },
      {
        "guideline_id": "GL-USPSTF-IPV-2018",
        "title": "Intimate Partner Violence, Elder Abuse, and Abuse of Vulnerable Adults: Screening",
        "publisher": "U.S. Preventive Services Task Force",
        "url": "https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/intimate-partner-violence-and-abuse-of-elderly-and-vulnerable-adults-screening",
        "version_or_year": "2018"
      },
      {
        "guideline_id": "GL-USPSTF-ALC-2018",
        "title": "Unhealthy Alcohol Use in Adolescents and Adults: Screening and Behavioral Counseling Interventions",
        "publisher": "U.S. Preventive Services Task Force",
        "url": "https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/unhealthy-alcohol-use-in-adolescents-and-adults-screening-and-behavioral-counseling-interventions",
        "version_or_year": "2018"
      },
      {
        "guideline_id": "GL-CDC-IMZ-2026",
        "title": "Adult Immunization Schedule by Medical Condition and Other Indication",
        "publisher": "Centers for Disease Control and Prevention",
        "url": "https://www.cdc.gov/vaccines/hcp/imz-schedules/adult-medical-condition.html",
        "version_or_year": "2026"
      }
    ]
  },
  "review": {
    "schema_validation": {
      "status": "not_started",
      "notes": "Run scripts/build.ps1 -Conformance."
    },
    "clinical_review": {
      "status": "not_started",
      "notes": "Awaiting clinician review; check the MRI staging of a low rectal tumor, the choice of dostarlimab alone for mismatch repair-deficient locally advanced disease, the restaging schedule and the definition of clinical complete response, the reading of loss of MSH2 and MSH6 with a negative germline panel and two somatic MSH2 variants, the management of immune-related hypothyroidism without holding treatment, and the watch-and-wait surveillance intervals."
    },
    "provenance_review": {
      "status": "not_started",
      "notes": "She died in 1956; the recent-death rule does not apply. Claims rest on the Handbook of Texas (by her biographer Susan Cayleff), the National Women's History Museum, two Gale reference entries, the Babe Didrikson Zaharias Foundation and Wikipedia. The site of her cancer and the operation are recorded as R because the sources call it colon cancer and name no operation; everything clinical is synthetic."
    },
    "safe_messaging_review": {
      "status": "not_started",
      "notes": "No mental health or substance claim is made; mood screens are synthetic and below the threshold for a safety assessment. Her death is recorded once, without detail. No relative, companion or historical physician is given a role in the modern episode; her husband appears only in the documented history, and her close companion Betty Dodd is not used."
    }
  }
}
